Publications

Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.
Moses BS, Slone WL, Thomas P, Evans R, Piktel D, Angel PM, Walsh CM, Cantrell PS, Rellick SL, Martin KH, Simpkins JW, Gibson LF.
Exp Hematol. 2016;44(1):50-59.

PMC4684957.

KAP1 promotes proliferation and metastatic progression of breast cancer cells.
Addison JB, Koontz C, Fugett JH, Creighton CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL, Livengood RH, Lin CC, Ruppert JM, Pugacheva EN, Ivanov AV.
Cancer Res. 2015;75(2):344-355.

PMC4297582.

A novel method to assess bone marrow purity is useful in determining blast percentage by flow cytometry in Acute Myeloid Leukemia and Myelodysplasia.
Aldawood AM, Kinkade Z, Rosado FG, Esan OA, Gibson LF, Vos JA.
Anal Hematology & Oncology. 2015;2(5):1038

PMC4507808.

Parkinson's Disease and home healthcare use and expenditures among elderly Medicare beneficiaries.
Bhattacharjee S, Metzger A, Tworek C, Wei W, Pan X, Sambamoorthi U.
Parkinsons.Dis. 2015;2015:606810

PMC4458280.

Three-dimensional microfluidic tri-culture model of the bone marrow microenvironment for study of acute lymphoblastic leukemia.
Bruce A, Evans R, Mezan R, Shi L, Moses BS, Martin KH, Gibson LF, Yang Y.
PLoS One. 2015;10(10):e0140506

PMC4619215.

A Phase I study of midostaurin and azacitidine in relapsed and ederly AML patients.
Cooper BW, Kindwall-Keller TL, Craig M, Creger RJ, Hamadani M, Tse WW, Lazarus HM.
Clin Lymphoma Myeloma Leuk. 2015;15(7):428-432.

PMC4484305.

High-fat, high-calorie diet enhances mammary carcinogenesis and local inflammation in MMTV-PyMT mouse model of breast cancer.
Cowen S, McLaughlin SL, Hobbs GR, Coad JE, Martin KH, Olfert IM, Vona-Davis LC.
Cancers (Basel). 2015;7(3):1125-1142.

PMC4586761.

Superior serum concentrations with posaconazole delayed-release tablets compared to suspension formulation in hematological malignancies.
Cumpston AD, Caddell R, Shillingburg A, Lu X, Wen S, Hamadani M, Craig M, Kanate AS.
Antimicrob Agents Chemother. 2015;59(8):4424-4428.

PMC4505228.

Modeling the bone marrow microenvironment's influence on leukemic disease.
Evans R, Martin KH, Moses BS, Slone WL, Hare I, Piktel D, Thomas P, Gibson LF.
Transl Biomed. 2015;6(2):14

PMC4710364.

Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells.
He Z, Li B, Rankin GO, Rojanasakul Y, Chen YC.
Oncol Lett. 2015;9(3):1444-1450.

PMC4314987.

ATP binding to neighbouring subunits and intersubunit allosteric coupling underlie proteasomal ATPase function.
Kim YC, Snoberger A, Schupp J, Smith DM.
Nat Commun. 2015;6:8520

PMC4608255.

Ileal mucosa-associated lymphoid tissue lymphoma presenting with small bowel obstruction: a case report.
Kinkade Z, Esan OA, Rosado FG, Craig M, Vos JA.
Diagn Pathol. 2015;10:105

PMC4504228.

Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells.
Li B, Gao Y, Rankin GO, Rojanasakul Y, Cutler SJ, Tu Y, Chen YC.
Cancer Lett. 2015;356(2 Pt B):418-433.

PMC4351971.

NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.
Loskutov YV, Kozyulina PY, Kozyreva VK, Ice RJ, Jones BC, Roston TJ, Smolkin MB, Ivanov AV, Wysolmerski RB, Pugacheva EN.
Oncogene. 2015;34(28):3662-3675.

PMC4369482.

SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma.
Luanpitpong S, Li J, Manke A, Brundage KM, Ellis E, McLaughlin SL, Angsutararux P, Chanthra N, Voronkova M, Chen YC, Wang L, Chanvorachote P, Pei M, Issaragrisil S, Rojanasakul Y.
Oncogene. 2015; [Epub ahead of print]

PMC Journal - In Process.

Seven Q-Tracks monitors of laboratory quality drive general performance improvement: experience from the College of American Pathologists Q-Tracks program 1999-2011.
Meier FA, Souers RJ, Howanitz PJ, Tworek JA, Perrotta PL, Nakhleh RE, Karcher DS, Bashleben C, Darcy TP, Schifman RB, Jones BA.
Arch Pathol Lab Med. 2015;139(6):762-775.


Health care expenditures associated with depression in adults with cancer.
Pan X, Sambamoorthi U.
J Community Support Oncol. 2015;13(7):240-247.

PMC4576451.

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.
Park J, Schlederer M, Schreiber M, Kim S, Ice RJ, Merkel O, Bilban M, Hofbauer S, Addison JB, Zou J, Ji CY, Bunting S, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick SC, Ivanov AV, Pugacheva EN, Bunting K, Moriggl R, Kenner L, Tse WW.
OncoTarget. 2015;6(24):20697-20710.

PMC4653036.

A comparison of tissue engineering based repair of calvarial defects using adipose stem cells from normal and osteoporotic rats.
Pei M, Li J, McConda DB, Wen S, Clovis NB, Danley SS.
Bone. 2015;78:1-10.

PMC4466199.

Impact of tissue-specific stem cells on lineage-specific differentiation: a focus on the musculoskeletal system.
Pizzute T, Lynch K, Pei M.
Stem Cell Rev. 2015;11(1):119-132.

PMC4326629.

Extranodal Marginal Zone Lymphoma of the lung: evolution from an underlying reactive lymphoproliferative disorder.
Rubenstein JN, Beatty C, Kinkade Z, Bryan C, Hogg JP, Gibson LF, Vos JA.
J Clin Exp Pathol. 2015;5(1)

PMC4597786.

Evolving concepts of chondrogenic differentiation: history, state-of-the-art and future perspectives.
Tang X, Fan L, Pei M, Zeng L, Ge Z.
Eur Cell Mater. 2015;30:12-27.


Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.
Veltri L, Cumpston AD, Shillingburg AS, Wen S, Luo J, Leadmon S, Watkins K, Craig M, Hamadani M, Kanate AS.
Cytotherapy. 2015;17(12):1785-1792.

PMC4700501.

Delineation of in vitro chondrogenesis of human synovial stem cells following preconditioning using decellularized matrix.
Zhang Y, Li J, Davis ME, Pei M.
Acta Biomater. 2015;20:39-50.

PMC4428941.

sb203580 preconditioning recharges matrix-expanded human adult stem cells for chondrogenesis in an inflammatory environment - A feasible approach for autologous stem cell based osteoarthritic cartilage repair.
Zhang Y, Pizzute T, Li J, He F, Pei M.
Biomaterials. 2015;64:88-97.

PMC4503335.

Melatonin reverses H2 O2 -induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway.
Zhou L, Chen X, Liu T, Gong Y, Chen S, Pan G, Cui W, Luo ZP, Pei M, Yang H, He F.
J Pineal Res. 2015;59(2):190-205.

PMC4523475.

Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.
Basu SK, Remick SC, Monga M, Gibson LF.
Clin Exp Metastasis. 2014;31(2):257-267.

PMC4482126.

Safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients: a prospective, observational study.
Bodge M, Shillingburg AS, Paul SR, Biondo L.
Pediatr Blood Cancer. 2014;61(6):1111-1113.


Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.
Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y.
Radiology. 2014;271(1):183-192.


Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma.
Craig M, Hanna WT, Cabanillas F, Chen CS, Esseltine DL, Neuwirth R, O'Connor OA.
Br.J Haematol. 2014;166(6):920-928.


Preparation, characterization and application of magnetic Fe3O4-CS for the adsorption of orange I from aqueous solutions.
Du Y, Pei M, He Y, Yu F, Guo W, Wang L.
PLoS One. 2014;9(10):e108647

PMC4182735.

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
Flinn IW, van der Jagt RH, Kahl BS, Wood P, Hawkins TE, Macdonald D, Hertzberg M, Kwan YL, Simpson D, Craig M, Kolibaba K, Issa S, Clementi R, Hallman DM, Munteanu M, Chen L, Burke JM.
Blood. 2014;123(19):2944-2952.

PMC4260975.

Diacetyl increases sensory innervation and substance p production in rat trachea.
Goravanahally MP, Hubbs AF, Fedan JS, Kashon ML, Battelli LA, Mercer RR, Goldsmith WT, Jackson MC, Cumpston AD, Frazer DG, Dey RD.
Toxicol Pathol. 2014;42(3):582-590.


Extracellular matrix modulates the biological effects of melatonin in mesenchymal stem cells.
He F, Liu X, Xiong K, Chen S, Zhou L, Cui W, Pan G, Luo ZP, Pei M, Gong Y.
J Endocrinol. 2014;223(2):167-180.


Twenty-five years of accomplishments of the college of american pathologists q-probes program for clinical pathology.
Howanitz PJ, Perrotta PL, Bashleben CP, Meier FA, Ramsey GE, Massie LW, Zimmerman RL, Karcher DS.
Arch Pathol Lab Med. 2014;138(9):1141-1149.


MicroRNA-155 broadly orchestrates inflammation-induced changes of microRNA expression in breast cancer.
Hu S, Zhu W, Zhang LF, Pei M, Liu MF.
Cell Res. 2014;24(2):254-257.

PMC3915901.

RepSox slows decay of CD34+ acute myeloid leukemia cells and decreasesT cell immunoglobulin mucin-3 expression.
Jajosky AN, Coad JE, Vos JA, Martin KH, Senft JR, Wenger SL, Gibson LF.
Stem Cells Transl Med. 2014;3(7):836-848.

PMC4073822.

Matrilin-3 chondrodysplasia mutations cause attenuated chondrogenesis, premature hypertrophy and aberrant response to TGF-beta in chondroprogenitor cells.
Jayasuriya CT, Zhou FH, Pei M, Wang Z, Lemme NJ, Haines P, Chen Q.
Int J Mol Sci. 2014;15(8):14555-14573.

PMC4159868.

Can arthroscopically harvested synovial stem cells be preferentially sorted using stage-specific embryonic antigen 4 antibody for cartilage, bone, and adipose regeneration?
Li J, Campbell DD, Bal GK, Pei M.
Arthroscopy. 2014;30(3):352-361.


Rejuvenation of chondrogenic potential in a young stem cell microenvironment.
Li J, Hansen KC, Zhang Y, Dong C, Dinu CZ, Dzieciatkowska M, Pei M.
Biomaterials. 2014;35(2):642-653.


Significance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.
Li JT, Ohliger J, Pei M.
Stem Cells Dev. 2014;23(11):1178-1194.

PMC4027988.

NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.
McLaughlin SL, Ice RJ, Rajulapati A, Kozyulina PY, Livengood RH, Kozyreva VK, Loskutov YV, Culp M, Weed SA, Ivanov AV, Pugacheva EN.
Mol Cancer Res. 2014;12(1):69-81.

PMC3946989.

Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells.
Pei M, Li JT, Zhang Y, Liu GH, Wei L, Zhang YY.
Cell Tissue Res. 2014;356(2):391-403.

PMC4128485.

Frequency monitoring of hemoglobin a1c, low-density lipoprotein, and urine protein laboratory testing: a college of american pathologists q-probes study.
Perrotta PL, Jones R, Souers RJ, Darcy TP, Howanitz PJ.
Arch Pathol Lab Med. 2014;138(8):1009-1014.


Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation.
Rauenzahn S, Truong Q, Cumpston AD, Goff L, Leadmon S, Evans K, Zhang J, Wen S, Craig M, Hamadani M, Kanate AS.
Biol Blood Marrow Transplant. 2014;20(3):415-420.

PMC4557764.

Abbott ARCHITECT iPhenytoin assay versus similar assays for measuring free phenytoin concentrations.
Tacker DH, Robinson R, Perrotta PL.
Labmedicine. 2014;45(2):176-181.


Abbott ARCHITECT iPhenytoin assay versus similar assays for measuring free phenytoin concentrations.
Tacker DH, Robinson R, Perrotta PL.
Lab Med. 2014;45(2):176-181.


Workflow analysis comparing manual and automated specimen processing for mass spectrometry-based vitamin d testing.
Tacker DH, Topardo J, Mahaffey C, Perrotta PL.
Lab Med. 2014;45(4):361-367.


Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration.
Toh WS, Foldager CB, Pei M, Hui JH.
Stem Cell Rev. 2014;10(5):686-696.


Limited utility of surveillance imaging for detecting disease relapse in patients with non-hodgkin lymphoma in first complete remission.
Truong Q, Shah N, Knestrick M, Curley B, Hu Y, Craig M, Hamadani M.
Clin Lymphoma Myeloma Leuk. 2014;14(1):50-55.


Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients.
Truong Q, Veltri L, Kanate AS, Hu Y, Craig M, Hamadani M, Cumpston AD.
Ann Hematol. 2014;93(4):677-682.


Use of high frequency ultrasound to monitor cervical lymph node alterations in mice.
Walk EL, McLaughlin S, Coad JE, Weed SA.
PLoS One. 2014;9(6):e100185

PMC4067293.

Demineralized bone matrix combined bone marrow mesenchymal stem cells, Bone Morphogenetic protein-2 and Transforming Growth Factor-beta3 gene promoted pig cartilage defect repair.
Wang X, Li Y, Han R, He C, Wang G, Wang J, Zheng J, Pei M, Wei L.
PLoS One. 2014;9(12):e116061

PMC4278773.

Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer.
Younis IR, George DJ, McManus TJ, Hurwitz H, Creel P, Armstrong AJ, Yu JJ, Bacon K, Hobbs GR, Peer CJ, Petros WP.
Cancer Chemother Pharmacol. 2014;73(5):991-997.

PMC4010098.

Anti-Inflammatory strategies in cartilage repair.
Zhang Y, Pizzute T, Pei M.
Tissue Eng Part B Rev. 2014;29(6):655-668.

PMC4241874.

A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration.
Zhang Y, Pizzute T, Pei M.
Cell Tissue Res. 2014;358(3):633-649.

PMC4234693.

Downregulation of RUNX1/CBFbeta by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
Zhao X, Chen A, Yan X, Zhang Y, He F, Hayashi Y, Dong Y, Rao Y, Li B, Conway RM, Maiques-Diaz A, Elf SE, Huang N, Zuber J, Xiao Z, Tse WW, Tenen DG, Wang Q, Chen W, Mulloy JC, Nimer SD, Huang G.
Blood. 2014;123(11):1729-1738.


Depression treatment patterns among individuals with osteoarthritis: a cross sectional study.
Agarwal P, Pan X, Sambamoorthi U.
BMC Psychiatry. 2013;13(1):121

PMC3640952.

Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease.
Ajmera M, Shen C, Pan X, Findley PA, Rust G, Sambamoorthi U.
Int J Chron Obstruct Pulmon Dis. 2013;8:287-294.

PMC3682815.

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies.
Awan FT, Kochuparambil ST, Falconer DE, Cumpston AD, Leadmon S, Watkins K, DeRemer D, Jillella A, Craig M, Hamadani M.
Bone Marrow Transplant. 2013;48(10):1279-1284.


Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF.
Chaudhary LN, Awan FT, Cumpston AD, Leadmon S, Watkins K, Tse WW, Craig M, Hamadani M.
J Clin Apher. 2013;28(5):359-367.


Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston AD, Craig M, Hamadani M, Abraham J, Hobbs GR, Sarwari AR.
Transpl Infect Dis. 2013;15(2):142-149.


Bone marrow osteoblast vulnerability to chemotherapy.
Gencheva M, Hare I, Kurian S, Fortney JE, Piktel D, Wysolmerski RB, Gibson LF.
Eur J Haematol. 2013;90(6):469-478.

PMC3662303.

Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.
Hamadani M, Gibson LF, Remick SC, Wen S, Petros WP, Tse WW, Brundage KM, Vos JA, Cumpston AD, Bunner P, Craig M.
J Clin Oncol. 2013;31(35):4416-4423.

PMC3842909.

Duration of cisplatin excretion in breast milk.
Hays KE, Ryu RJ, Swisher EM, Reed E, McManus T, Rybeck B, Petros WP, Hebert MF.
J Hum Lact. 2013;29(4):469-472.

PMC4041270.

Extracellular matrix enhances differentiation of adipose stem cells from infrapatellar fat pad toward chondrogenesis.
He F, Pei M.
J Tissue Eng Regen Med. 2013;7(1):73-84.


NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.
Ice RJ, McLaughlin SL, Livengood RH, Culp M, Eddy ER, Ivanov AV, Pugacheva EN.
Cancer Res. 2013;73(10):3168-3180.

PMC3667743.

Salvage bone marrow harvest in patients failing Plerixafor-based stem cell mobilization attempt: feasibility and autologous transplantation outcomes.
Kanate AS, Watkins K, Cumpston AD, Craig M, Hamadani M.
Biol Blood Marrow Transplant. 2013;19(7):1133-1135.


Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
LaSala PR, Ekhmimi T, Hill AK, Farooqi I, Perrotta PL.
J Clin Microbiol. 2013;51(1):311-313.

PMC3536223.

Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma.
Li M, Cushing SK, Zhang J, Suri S, Evans R, Petros WP, Gibson LF, Ma D, Liu Y, Wu NQ.
ACS Nano. 2013;7(6):4967-4976.

PMC3732798.

Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells.
Luanpitpong S, Chanvorachote P, Stehlik C, Tse WW, Callery PS, Wang LY, Rojanasakul Y.
Mol Biol Cell. 2013;24(6):858-869.

PMC3596255.

MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.
Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce CM, Chakravarti A, Jin VX, Lautenschlaeger T.
Clin Cancer Res. 2013;19(19):5423-5433.

PMC3823052.

The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells.
Pacurari M, Addison JB, Bondalapati N, Wan YW, Luo D, Qian Y, Castranova V, Ivanov AV, Guo NL.
Int J Oncol. 2013;43(2):548-560.

PMC3775564.

Warm Autoimmune Hemolytic Anemia with a direct antiglobulin test positive for C3 and negative for IgG: a case study and analytical literature review of incidence and severity.
Palla AR, Khimani F, Craig M.
Clin Med Insights Case Rep. 2013;6:57-60.

PMC3623608.

Repair of large animal partial-thickness cartilage defects through intraarticular injection of matrix-rejuvenated synovium-derived stem cells.
Pei M, He F, Li J, Tidwell JE, Jones AC, McDonough EB.
Tissue Eng Part A. 2013;19(9-10):1144-1154.


Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis.
Pei M, Zhang Y, Li J, Chen D.
Stem Cells Dev. 2013;22(6):889-900.

PMC3585742.

Molecular insights into the progression of crystalline silica-induced pulmonary toxicity in rats.
Sellamuthu R, Umbright C, Roberts JR, Cumpston AD, McKinney W, Chen BT, Frazer D, Li S, Kashon ML, Joseph PN.
J Appl Toxicol. 2013;33(4):301-312.


Reconstruction of an in vitro niche for the transition from intervertebral disc development to nucleus pulposus regeneration.
Shoukry M, Li J, Pei M.
Stem Cells Dev. 2013;22(8):1162-1176.

PMC3613965.

Incidence and pattern of graft-versus-host disease in patients undergoing allogeneic transplantation after nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin.
Veltri L, Regier M, Cumpston AD, Leadmon S, Tse WW, Craig M, Hamadani M.
Bone Marrow Res. 2013;2013:414959

PMC3652129.

Adipocytes as a critical component of the tumor microenvironment.
Vona-Davis LC, Gibson LF.
Leuk Res. 2013;37(5):483-484.

PMC4038928.

Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation.
Awan FT, Osman S, Kochuparambil ST, Gibson LF, Remick SC, Abraham J, Craig M, Jillella A, Hamadani M.
Bone Marrow Transplant. 2012;47(1):146-148.


Plerixafor salvage is safe and effective in hard-to-mobilize patients undergoing cemotherapy and filgrastim-based peripheral blood progenitor cell mobilization.
Awan FT, Kochuparambil ST, DeRemer D, Cumpston AD, Craig M, Jillella A, Hamadani M.
J Oncol. 2012;2012:931071

PMC3335320.

Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.
Cieply B, Riley P, Pifer PM, Widmeyer J, Addison JB, Ivanov AV, Denvir J, Frisch SM.
Cancer Res. 2012;72(9):2440-2453.

PMC3342427.

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory Acute Myelogenous Leukemia: results from the CLASSIC I trial.
Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, Ganguly S, Avigan D, Craig M, Collins R, Maris M, Kovacsovics T, Goldberg S, Seiter K, Hari P, Greiner J, Vey N, Recher C, Ravandi F, Wang ES, Vasconcelles M, Huebner D, Kantarjian HM.
J Clin Oncol. 2012;30(20):2492-2499.


Subcellular relocation of histone deacetylase 4 regulates growth plate chondrocyte differentiation through Ca2+/calmodulin-dependent kinase IV.
Guan Y, Chen Q, Yang X, Haines P, Pei M, Terek R, Wei X, Zhao T, Wei L.
Am J Physiol Cell Physiol. 2012;303(1):C33-C40.

PMC3404523.

Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
Guo Y, Fu P, Zhu H, Reed E, Remick SC, Petros WP, Mueller MD, Yu JJ.
Oncol Rep. 2012;27(1):286-292.


Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell obilization in patients with multiple myeloma treated with novel induction therapies.
Hamadani M, Kochuparambil ST, Osman S, Cumpston AD, Leadmon S, Bunner P, Watkins K, Morrison D, Speir E, DeRemer D, Kota V, Jillella A, Craig M, Awan FT.
Biol Blood Marrow Transplant. 2012;18(7):1128-1135.


Rejuvenation of nucleus pulposus cells using extracellular matrix deposited by synovium-derived stem cells.
He F, Pei M.
Spine (Phila Pa 1976.). 2012;37(6):459-469.


Localized delivery of chemotherapy to the cervix for radiosensitization.
Hodge LS, Downs LS, Jr., Chura JC, Thomas SG, Callery PS, Soisson AP, Kramer P, Wolfe SS, Tracy TS.
Gynecol Oncol. 2012;127(1):121-125.


A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
Hosein PJ, Craig M, Tallman MS, Boccia RV, Hamilton BL, Lewis JJ, Lossos IS.
Am J Hematol. 2012;87(1):111-114.


Synovium-derived stem cells: a tissue-specific stem cell for cartilage engineering and regeneration.
Jones BA, Pei M.
Tissue Eng Part B Rev. 2012;18(4):301-311.


Comparison of analytical and clinical performance of three methods for detection of Clostridium difficile.
LaSala PR, Svensson AM, Mohammad AA, Perrotta PL.
Arch Pathol Lab Med. 2012;136(5):527-531.


Cell senescence: a challenge in cartilage engineering and regeneration.
Li JT, Pei M.
Tissue Eng Part B Rev. 2012;


Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT((R))/leucovorin.
Peer CJ, McManus TJ, Hurwitz HI, Petros WP.
J Chromatogr B Analyt Technol Biomed Life Sci. 2012;898:32-37.


Glutathione conjugation of busulfan produces a hydroxyl radical-trapping dehydroalanine metabolite.
Peer CJ, Younis IR, Leonard SS, Gannett PM, Minarchick VC, Kenyon AJ, Rojanasakul Y, Callery PS.
Xenobiotica. 2012;42(12):1170-1177.


Modulation of In Vitro microenvironment facilitates synovium-derived stem cell-based nucleus pulposus tissue regeneration.
Pei M, Shoukry M, Li J, Daffner SD, France JC, Emery SE.
Spine (Phila Pa 1976.). 2012;


Extracellular matrix deposited by synovium-derived stem cells delays replicative senescent chondrocyte dedifferentiation and enhances redifferentiation.
Pei M, He F.
J Cell Physiol. 2012;227(5):2163-2174.

PMC3265606.

Effects of tobacco smoking and nicotine on cancer treatment.
Petros WP, Younis IR, Ford JN, Weed SA.
Pharmacotherapy. 2012;32(10):920-931.

PMC3499669.

Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts.
Rellick SL, Piktel D, Walton C, Hall B, Petros WP, Fortney JE, Gencheva M, Denvir J, Hobbs GR, Craig M, Gibson LF.
Cytokine. 2012;58(2):245-252.

PMC3319530.

Bone marrow osteoblast damage by chemotherapeutic agents.
Rellick SL, O'Leary HA, Piktel D, Walton C, Fortney JE, Akers SM, Martin KH, Denvir J, Boskovic G, Primerano DA, Vos JA, Bailey NG, Gencheva M, Gibson LF.
PLoS One. 2012;7(2):e30758

PMC3281873.

Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis.
Ross AL, Slain D, Cumpston AD, Bryant AM, Hamadani M, Craig M.
Int J Antimicrob Agents. 2012;40(6):557-561.


Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit.
Sweet MA, Cumpston AD, Briggs F, Craig M, Hamadani M.
Am J Infect Control. 2012;40(10):931-934.


Azacitidine-associated Sweet's syndrome.
Trickett HB, Cumpston AD, Craig M.
Am J Health Syst Pharm. 2012;69(10):869-871.


Chronic condition clusters and polypharmacy among adults.
Vyas A, Pan X, Sambamoorthi U.
Int J Family Med. 2012;2012:193168

PMC3415173.

A smoking-associated 7-gene signature for lung cancer diagnosis and prognosis.
Wan YW, Raese RA, Fortney JE, Xiao C, Luo D, Cavendish J, Gibson LF, Castranova V, Qian Y, Guo NL.
Int J Oncol. 2012;41(4):1387-1396.

PMC3481011.

Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage.
Wei F, Zhou J, Wei X, Zhang J, Fleming BC, Terek R, Pei M, Chen Q, Liu T, Wei L.
Osteoarthritis Cartilage. 2012;20(7):755-763.

PMC3374008.

The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation.
White D, Rafalska-Metcalf IU, Ivanov AV, Corsinotti A, Peng H, Lee SC, Trono D, Janicki SM, Rauscher FJ, III.
Mol Cancer Res. 2012;10(3):401-414.


Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.
Akers SM, Rellick SL, Fortney JE, Gibson LF.
Leuk Res. 2011;35(6):705-711.

PMC3099259.

A conserved F box regulatory complex controls proteasome activity in Drosophila.
Bader M, Benjamin S, Wapinski OL, Smith DM, Goldberg AL, Steller H.
Cell. 2011;145(3):371-382.

PMC3108249.

A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.
Bryant AM, Slain D, Cumpston AD, Craig M.
Int J Antimicrob Agents. 2011;37(3):266-269.


A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE).
Bullock KE, Petros WP, Younis I, Uronis HE, Morse MA, Blobe GC, Zafar SY, Gockerman JP, Lager JJ, Truax R, Meadows KL, Howard LA, O'Neill MM, Broadwater G, Hurwitz HI, Bendell JC.
Cancer Chemother Pharmacol. 2011;67(2):465-474.

PMC4086252.

Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors.
Castaneda C, Meadows KL, Truax R, Morse MA, Kaufmann SH, Petros WP, Zhu Y, Statkevich P, Cutler DL, Hurwitz HI.
Cancer Chemother Pharmacol. 2011;67(2):455-463.


Reversible and irreversible protein glutathionylation: biological and clinical aspects.
Cooper AJ, Pinto JT, Callery PS.
Expert Opin Drug Metab Toxicol. 2011;

PMC3116085.

Cysteine S-conjugate beta-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents.
Cooper AJ, Krasnikov BF, Niatsetskaya ZV, Pinto JT, Callery PS, Villar MT, Artigues A, Bruschi SA.
Amino Acids. 2011;41(1):7-27.

PMC2898922.

Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.
Deriziotis P, Andre R, Smith DM, Goold R, Kinghorn KJ, Kristiansen M, Nathan JA, Rosenzweig R, Krutauz D, Glickman MH, Collinge J, Goldberg AL, Tabrizi SJ.
EMBO J. 2011;30(15):3065-3077.

PMC3160194.

Successful vapor-based endometrial ablation: in vivo peri-hysterectomy study.
Garza-Leal J, Hernandez I, Castillo L, Jessop ML, Chill N, Coad JE.
J Minim Invasive Gynecol. 2011;18(4):445-448.


The evolving role of statins in hematopoietic stem and progenitor cell transplantation.
Hamadani M, Craig M, Gibson LF, Remick SC.
Am J Blood Res. 2011;1(1):57-64.

PMC3301410.

Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.
Hamadani M, Craig M, Phillips GS, Abraham J, Tse WW, Cumpston AD, Gibson LF, Remick SC, Bunner P, Leadmon S, Elder P, Hofmeister C, Penza S, Efebera Y, Andritsos L, Garzon R, Benson DM, Blum W, Devine SM.
Hematol Oncol. 2011;29(4):202-210.

PMC3557914.

Functional Analysis of KAP1 Genomic Recruitment.
Iyengar S, Ivanov AV, Jin VX, Rauscher FJ, III, Farnham PJ.
Mol Cell Biol. 2011;31(9):1833-1847.

PMC3133220.

Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation.
Kanate AS, Craig M, Cumpston AD, Saad A, Hobbs GR, Leadmon S, Bunner P, Watkins K, Bulian D, Gibson LF, Abraham J, Remick SC, Hamadani M.
Hematol Oncol Stem Cell Ther. 2011;4(4):149-156.


Creation of an in vitro microenvironment to enhance human fetal synovium-derived stem cell chondrogenesis.
Li J, He F, Pei M.
Cell Tissue Res. 2011;345(3):357-365.


Optimization of an in vitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering.
Li J, Pei M.
Tissue Eng Part A. 2011;17(5-6):703-712.


A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context.
Lin CC, Liu LZ, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM.
Mol Cell Biol. 2011;31(12):2513-2527.

PMC3133414.

Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines.
Link BK, Brooks J, Wright K, Pan X, Voelker M, Chrischilles E.
Leuk Lymphoma. 2011;52(6):994-1002.

PMC3601377.

Adalimumab real-world dosage pattern and predictors of weekly dosing: patients with Crohn's disease in the United States.
Loftus EV, Jr., Pan X, Zurawski P, Mulani P, Chao J.
J Crohns Colitis. 2011;5(6):550-554.


Pulmonary particulate matter and systemic microvascular dysfunction.
Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Moseley AM, Cumpston JL, Goodwill AG, Frisbee SJ, Perrotta PL, Brock RW, Frisbee JC, Boegehold MA, Frazer DG, Chen BT, Castranova V, HEI Health Review Committee.
Res Rep Health Eff Inst. 2011;(164):3-48.


A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering.
Pei M, Li JT, Shoukry M, Zhang Y.
Eur Cell Mater. 2011;22:333-343.


Three dimensional cell expansion substrate for cartilage tissue engineering and regeneration: a comparision in decellularized matrix deposited by synovium-derived stem cells and chondrocytes.
Pei M, He F, Wei L.
J Tissue Sci Eng. 2011;2(2):1000104


Expansion on extracellular matrix deposited by human bone marrow stromal cells facilitates stem cell proliferation and tissue-specific lineage potential.
Pei M, He F, Kish VL.
Tissue Eng Part A. 2011;17(23-24):3067-3076.

PMC3226057.

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.
Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE.
Blood. 2011;117(22):5827-5834.

PMC3112033.

Respiratory syncytial virus infection in human bone marrow stromal cells.
Rezaee F, Gibson LF, Piktel D, Othumpangat S, Piedimonte G.
Am J Respir Cell Mol Biol. 2011;45(2):277-286.

PMC3175557.

Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population.
Rogers JE, Cumpston AD, Newton MD, Craig M.
Transpl Infect Dis. 2011;13(5):480-484.


ATP binds to proteasomal ATPases in pairs with distinct functional effects, implying an ordered reaction cycle.
Smith DM, Fraga H, Reis C, Kafri G, Goldberg AL.
Cell. 2011;144(4):526-538.

PMC3063399.

AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes.
Snyder BN, Cho Y, Qian Y, Coad JE, Flynn DC, Cunnick JM.
Eur J Cell Biol. 2011;90(5):376-389.

PMC3085893.

Effects of different carboxylic ester spacers on chemical stability, release characteristics, and anticancer activity of mono-PEGylated curcumin conjugates.
Wichitnithad W, Nimmannit U, Callery PS, Rojsitthisak P.
J Pharm Sci. 2011;100(12):5206-5218.


Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines.
Wichitnithad W, O'Callaghan JP, Miller DB, Train BC, Callery PS.
Bioorg Med Chem. 2011;19(24):7482-7492.


A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer.
Wong NS, Meadows KL, Rosen LS, Adjei AA, Kaufmann SH, Morse MA, Petros WP, Zhu Y, Statkevich P, Cutler DL, Meyers ML, Hurwitz HI.
Cancer Invest. 2011;29(9):617-625.

PMC4101887.

Curcumin prevents corticosterone-induced neurotoxicity and abnormalities of neuroplasticity via 5-HT receptor pathway.
Xu Y, Li S, Vernon MM, Pan J, Chen L, Barish PA, Zhang Y, Acharya AP, Yu J, Govindarajan SS, Boykin E, Pan X, O'Donnell JM, Ogle WO.
J Neurochem. 2011;118(5):784-795.


VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.
Akers SM, O'Leary HA, Minnear FL, Craig M, Vos JA, Coad JE, Gibson LF.
Exp Hematol. 2010;38(9):733-743.

PMC2929642.

A polymorphic variant of AFAP-110 enhances cSrc activity.
Clump DA, Yu JJ, Cho Y, Gao R, Jett J, Zot HM, Cunnick JM, Snyder B, Clump AC, Dodrill M, Gannett PM, Coad JE, Shurina R, Figg WD, Reed E, Flynn DC.
Transl Oncol. 2010;3(4):276-285.

PMC2915419.

Control of plasma uric acid in adults at risk for Tumor Lysis Syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter Phase III study.
Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey BR, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown A, Jr., Laadem A, Seiter K.
J Clin Oncol. 2010;28(27):4207-4213.


A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors.
Dugan E, Truax R, Meadows KL, Nixon AB, Petros WP, Favaro J, Fernando NH, Morse MA, Blobe GC, Hurwitz HI.
Anticancer Res. 2010;30(4):1251-1256.

PMC4103189.

How we approach patient evaluation for hematopoietic stem cell transplantation.
Hamadani M, Craig M, Awan FT, Devine SM.
Bone Marrow Transplant. 2010;45(8):1259-1268.


Subcellular localization of the amide class herbicide 3,4-dichloropropionanilide (DCPA) in T cells and hepatocytes.
Hanson ML, Peer CJ, Brundage RA, Callery PS, Brundage KM, Schafer R, Eremin S, Barnett JB.
J Toxicol Environ Health A. 2010;73(1):1-4.

PMC2888467.

Phase II study of clofarabine monotherapy in previously untreated older adults with Acute Myeloid Leukemia and unfavorable prognostic factors.
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S.
J Clin Oncol. 2010;28(4):549-555.


Meeting Report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010.
Lesinski GB, Carson WE, Repasky EA, Wei WZ, Kalinski P, Lotze MT, June CH, Petros WP, Muthusamy N, Olencki T.
J Immunother. 2010;33(7):659-662.

PMC3793645.

VE-cadherin regulates Philadelphia chromosome positive acute lymphoblastic leukemia sensitivity to apoptosis.
O'Leary HA, Akers SM, Piktel D, Walton C, Fortney JE, Martin KH, Craig M, Coad JE, Gibson LF.
Cancer Microenviron. 2010;3(1):67-81.

PMC2990486.

Failure of xenoimplantation using porcine synovium-derived stem cell-based cartilage tissue constructs for the repair of rabbit osteochondral defects.
Pei M, Yan Z, Shoukry M, Boyce BM.
J Orthop Res. 2010;28(8):1064-1070.


Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway.
Rezaee F, Rellick SL, Piedimonte G, Akers SM, O'Leary HA, Martin KH, Craig M, Gibson LF.
PLoS One. 2010;5(3):e9690

PMC2837737.

Fit-for-purpose evaluation of architect i1000SR immunoassay analyzer.
Rukhsana J, Perrotta PL, Okorodudu AO, Petersen JR, Mohammad AA.
Clin Chim Acta. 2010;411(11-12):798-801.


Meniscus reconstruction through coculturing meniscus cells with synovium-derived stem cells on small intestine submucosa--a pilot study to engineer meniscus tissue constructs.
Tan Y, Zhang Y, Pei M.
Tissue Eng Part A. 2010;16(1):67-79.


Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation.
Wei L, Kanbe K, Lee M, Wei X, Pei M, Sun X, Terek R, Chen Q.
Dev Biol. 2010;341(1):236-245.

PMC2862458.

Identification of isobaric product ions in electrospray ionization mass spectra of fentanyl using multistage mass spectrometry and deuterium labeling.
Wichitnithad W, McManus TJ, Callery PS.
Rapid Commun Mass Spectrom. 2010;24(17):2547-2553.


HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.
Yu JJ, Fu PF, Pink JJ, Dawson D, Wasman JK, Orem JN, Mwanda WO, Zhu HL, Liang XB, Guo Y, Petros WP, Mitsuyasu RT, Wabinga H, Remick SC.
PLoS One. 2010;5(5):e10477

PMC2871792.

Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the eukaryotic proteasome-ATPase interactions.
Yu Y, Smith DM, Kim HM, Rodriguez V, Goldberg AL, Cheng Y.
EMBO J. 2010;29(3):692-702.

PMC2830694.

Building a statewide clinical trials network for cancer care in West Virginia.
Abraham J, Keresztury J, Azar J, Monga M, Bowers T, Jones MP, Tirona MT, Pollock J, Coonley C, Jubelirer SJ, Frame J, Fogg P, Getto M, Filburn S, Naim JO, Lucas D, Petros WP, Hall S, Remick SC.
WV Med J. 2009;105 Spec No:6-11.


CD14-negative isolation enhances chondrogenesis in synovial fibroblasts.
Bilgen B, Ren Y, Pei M, Aaron RK, Ciombor DM.
Tissue Eng Part A. 2009;15(11):3261-3270.

PMC2792095.

Coculture of synovium-derived stem cells and nucleus pulposus cells in serum-free defined medium with supplementation of transforming growth factor-beta1: a potential application of tissue-specific stem cells in disc regeneration.
Chen S, Emery SE, Pei M.
Spine (Phila Pa 1976.). 2009;34(12):1272-1280.


Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations.
Dabkowski ER, Williamson CL, Bukowski VC, Chapman RS, Leonard SS, Peer CJ, Callery PS, Hollander JM.
Am J Physiol Heart Circ Physiol. 2009;296(2):H359-H369.

PMC2643887.

Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.
Dugan E, Truax R, Meadows KL, Blobe GC, Morse MA, Fernando NH, Gockerman JP, Petros WP, Hurwitz HI.
Anticancer Res. 2009;29(12):5149-5153.

PMC4103184.

Bendamustine-associated hemolytic anemia.
Glance LE, Cumpston AD, Kanate AS, Remick SC.
Ann Pharmacother. 2009;43(11):1903-1906.


Reconstruction of an in vitro tissue-specific microenvironment to rejuvenate synovium-derived stem cells for cartilage tissue engineering.
He F, Chen X, Pei M.
Tissue Eng Part A. 2009;15(12):3809-3821.


Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines.
Malek RS, Kang HW, Coad JE, Koullick E.
J Endourol. 2009;23(5):837-845.


Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?
McMahon N, Cheng TY, Beasley GM, Spasojevic I, Petros WP, Augustine CK, Zipfel P, Padussis JC, Sanders G, Tyler DS.
Ann Surg Oncol. 2009;16(4):953-961.

PMC3872993.

Potential biomarkers of smoked fentanyl utilizing pyrolysis gas chromatography-mass spectrometry.
Nishikawa RK, Bell SC, Kraner JC, Callery PS.
J Anal Toxicol. 2009;33(8):418-422.


NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection.
Othumpangat S, Gibson LF, Samsell L, Piedimonte G.
PLoS One. 2009;4(7):e6444

PMC2715860.

Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy.
Pei M, Chen D, Li J, Wei L.
Differentiation. 2009;78(5):260-268.


Melatonin enhances cartilage matrix synthesis by porcine articular chondrocytes.
Pei M, He F, Wei L, Rawson A.
J Pineal Res. 2009;46(2):181-187.


Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs.
Pei M, He F, Boyce BM, Kish VL.
Osteoarthritis Cartilage. 2009;17(6):714-722.


Epigenetic gene silencing by the SRY protein is mediated by a KRAB-O protein that recruits the KAP1 co-repressor machinery.
Peng HZ, Ivanov AV, Oh HJ, Lau YF, Rauscher FJ, III.
J Biol Chem. 2009;284(51):35670-35680.

PMC2790998.

Molecular diagnostics in hemostatic disorders.
Perrotta PL, Svensson AM.
Clin Lab Med. 2009;29(2):367-390.


Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma.
Younis IR, Malone S, Friedman HS, Schaaf LJ, Petros WP.
Cancer Chemother Pharmacol. 2009;63(3):517-524.

PMC3914774.

Influence of pH on the dissolution of folic acid supplements.
Younis IR, Stamatakis MK, Callery PS, Meyer-Stout PJ.
Int J Pharm. 2009;367(1-2):97-102.


A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer.
Armstrong AJ, Creel P, Turnbull J, Moore C, Jaffe TA, Haley S, Petros WP, Yenser S, Gockerman JP, Sleep D, Hurwitz H, George DJ.
Clin Cancer Res. 2008;14(19):6270-6276.


Metabolism of the cysteine S-conjugate of busulfan involves a {beta}-lyase reaction.
Cooper AJ, Younis IR, Niatsetskaya ZV, Krasnikov BF, Pinto JT, Petros WP, Callery PS.
Drub Metab Dispos. 2008;36:1546-1552.

PMC2587289.

A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Czito BG, Cohen DP, Kelsey CR, Lockhart AC, Bendell JC, Willett CG, Petros WP, D'Amico TA, Truax R, Hurwitz HI.
Int J Radiat Oncol Biol Phys. 2008;70(4):1066-1072.


Direct injection mass spectrometric confirmation of multiple drugs in overdose cases from postmortem blood using electrospray ionization-tandem mass spectrometry and MS(3).
Peer CJ, Clay DJ, Glover HL, Renninger KL, Kraner JC, Callery PS.
J Anal Toxicol. 2008;32(8):709-714.


Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins.
Pei M, Luo J, Chen Q.
Osteoarthritis Cartilage. 2008;16(9):1110-1117.

PMC2596998.

Engineering of functional cartilage tissue using stem cells from synovial lining: a preliminary study.
Pei M, He F, Kish VL, Vunjak-Novakovic G.
Clin Orthop Relat Res. 2008;466(8):1880-1889.

PMC2584267.

Synovium-derived stem cell-based chondrogenesis.
Pei M, He F, Vunjak-Novakovic G.
Differentiation. 2008;76(10):1044-1056.

PMC2772098.

Proteomics: moving from a discovery to a quality assurance tool.
Perrotta PL.
Transfusion (Paris). 2008;48(3):408-410.


Comparison of four energy-based vascular sealing and cutting instruments: a porcine model.
Person B, Vivas DA, Ruiz D, Talcott M, Coad JE, Wexner SD.
Surg Endosc. 2008;22(2):534-538.


Morphology controllable nanostructured chitosan matrix and its cytocompatibility.
Qi L, Pal S, Dutta P, Seehra M, Pei M.
J Biomed Mater Res A. 2008;87(1):236-244.


Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases.
Rabl J, Smith DM, Yu Y, Chang SC, Goldberg AL, Cheng Y.
Mol Cell. 2008;30(3):360-368.


Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Rao AV, Younis IR, Sand GJ, Spasojevic I, Adams DJ, DeCastro CM, Gockerman JP, Peterson BL, Petros WP, Moore JO, Rizzieri DA.
Leuk Lymphoma. 2008;49(8):1523-1529.


Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.
Sarma K, Margueron R, Ivanov AV, Pirrotta V, Reinberg D.
Mol Cell Biol. 2008;28(8):2718-2731.

PMC2293112.

Trace evidence of trans-phenylpropene as a marker of smoked methamphetamine.
Shakleya DM, Plumley AE, Kraner JC, Bell SC, Callery PS.
J Anal Toxicol. 2008;32(8):705-708.


Can positron emission tomography be used as a staging tool for small-cell lung cancer?
Vinjamuri M, Craig M, Campbell-Fontaine A, Almubarak M, Gupta NC, Rogers JS.
Clin Lung Cancer. 2008;9(1):30-34.


Effect of morphine sulfate on neonatal neutrophil chemotaxis.
Yossuck P, Nightengale BJ, Fortney JE, Gibson LF.
Clin J Pain. 2008;24(1):76-82.


Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1.
Younis IR, Elliott M, Peer CJ, Cooper AJ, Pinto JT, Konat GW, Kraszpulski M, Petros WP, Callery PS.
J Pharmacol Exp Ther. 2008;327(3):770-776.

PMC2678891.

Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing.
Zeng L, Yap KL, Ivanov AV, Wang X, Mujtaba S, Plotnikova OV, Rauscher FJ, Zhou MM.
Nat Struct Mol Biol. 2008;15(6):626-633.

PMC3331790.

SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis.
Zhou XD, Coad JE, Ducatman BS, Agazie YM.
Histopathology. 2008;53(4):389-402.


The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M, Cumpston AD, Hobbs GR, Devetten MP, Sarwari AR, Ericson SG.
Bone Marrow Transplant. 2007;39(8):477-482.


Regulation of protein tyrosine phosphatase 1B by sumoylation.
Dadke S, Cotteret S, Yip SC, Jaffer ZM, Haj F, Ivanov AV, Rauscher FJ, III, Shuai K, Ng T, Neel BG, Chernoff J.
Nat Cell Biol. 2007;9(1):80-85.


Clinical evaluation of endometriosis and differential response to surgical therapy with and without application of Oxiplex/AP* adhesion barrier gel.
diZerega GS, Coad JE, Donnez J.
Fertil Steril. 2007;87(3):485-489.


TNF-alpha-based accentuation in cryoinjury--dose, delivery, and response.
Goel R, Swanlund D, Coad JE, Paciotti GF, Bischof JC.
Mol Cancer Ther. 2007;6(7):2039-2047.


ATP-induced structural transitions in PAN, the proteasome-regulatory ATPase complex in Archaea.
Horwitz AA, Navon A, Groll M, Smith DM, Reis C, Goldberg AL.
J Biol Chem. 2007;282(31):22921-22929.


A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
Hurwitz HI, Cohen RB, McGovren JP, Hirawat S, Petros WP, Natsumeda Y, Yoshinari T.
Cancer Chemother Pharmacol. 2007;59(1):139-147.


PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing.
Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, Schultz DC, Psulkowski E, Fredericks WJ, White DE, Maul GG, Sadofsky MJ, Zhou MM, Rauscher FJ, III.
Mol Cell. 2007;28(5):823-837.


Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS, Ivanova T, Kurash J, Ivanov AV, Chuikov S, Gizatullin F, Herrera-Medina EM, Rauscher FJ, III, Reinberg D, Barlev NA.
Mol Cell Biol. 2007;27(19):6756-6769.

PMC2099237.

Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
Li P, Callery PS, Gan LS, Balani SK.
Drub Metab Dispos. 2007;35(7):1203-1208.


Esterase inhibition attribute of grapefruit juice leading to a new drug interaction.
Li P, Callery PS, Gan LS, Balani SK.
Drub Metab Dispos. 2007;35(7):1023-1031.


Osteoporosis risk screening for women in a community pharmacy.
Liu Y, Nevins JC, Carruthers KM, Doucette WR, McDonough RP, Pan X.
J Am Pharm Assoc (2003). 2007;47(4):521-526.


Direct-injection mass spectrometric method for the rapid identification of fentanyl and norfentanyl in postmortem urine of six drug-overdose cases.
Peer CJ, Shakleya DM, Younis IR, Kraner JC, Callery PS.
J Anal Toxicol. 2007;31(8):515-521.


Thermal degradation analysis of amino acids in fingerprint residue by pyrolysis GC-MS to develop new latent fingerprint developing reagents.
Richmond-Aylor A, Bell SC, Callery PS, Morris K.
J Forensic Sci. 2007;52(2):380-382.


Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry.
Smith DM, Chang SC, Park S, Finley D, Cheng Y, Goldberg AL.
Mol Cell. 2007;27(5):731-744.

PMC2083707.

Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells.
Wang L, O'Leary HA, Fortney JE, Gibson LF.
Blood. 2007;110(9):3334-3344.

PMC2200915.

Chemotherapy disrupts activity of translational regulatory proteins in bone marrow stromal cells.
Clutter SD, Fortney JE, Gibson LF.
Exp Hematol. 2006;34(11):1522-1531.


Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel.
Cox MC, Low J, Lee J, Walshe J, Denduluri N, Berman A, Permenter MG, Petros WP, Price DK, Figg WD, Sparreboom A, Swain SM.
Clin Cancer Res. 2006;12(15):4636-4640.


A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract.
Czito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando NH, Hurwitz HI.
Cancer Invest. 2006;24(1):9-17.


Biliary cystadenomas: hormone receptor expression and clinical management.
Daniels JA, Coad JE, Payne WD, Kosari K, Sielaff TD.
Dig Dis Sci. 2006;51(3):623-628.


Proteomic approaches to dissect platelet function: Half the story.
Gnatenko DV, Perrotta PL, Bahou WF.
Blood. 2006;108(13):3983-3991.

PMC1895451.

Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, Bomgaars L, Blaney SM, Kun LE, Boyett JM.
Clin Cancer Res. 2006;12(5):1540-1546.


Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors.
Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, Pruitt AF, Klein A, Case B, Thrall DE, Needham D, Dewhirst MW.
Clin Cancer Res. 2006;12(13):4004-4010.


Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma.
Laudi N, Arora M, Burns L, McGlave P, Miller JL, Bohac G, Rogers T, Barker JN, Coad JE, Weisdorf DJ.
Am J Hematol. 2006;81(7):519-524.


Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells.
Lu M, Dou QP, Kitson RP, Smith DM, Goldfarb RH.
J Cell Biochem. 2006;97(1):122-134.


Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation.
Moungjaroen J, Nimmannit U, Callery PS, Wang LY, Azad N, Lipipun V, Chanvorachote P, Rojanasakul Y.
J Pharmacol Exp Ther. 2006;319(3):1062-1069.


Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression.
Negorev DG, Vladimirova OV, Ivanov AV, Rauscher FJ, III, Maul GG.
J Virol. 2006;80(16):8019-8029.

PMC1563809.

Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplant.
Price S, Cumpston AD, Altaha R.
Hematology. 2006;11(1):43-44.


Epoxidation of the methamphetamine pyrolysis product, trans-phenylpropene, to trans-phenylpropylene oxide by CYP enzymes and stereoselective glutathione adduct formation.
Sanga M, Younis IR, Tirumalai PS, Bland TM, Banaszewska M, Konat GW, Tracy TS, Gannett PM, Callery PS.
Toxicol Appl Pharmacol. 2006;211(2):148-156.


Identification of N,N-dimethylamphetamine formed by methylation of methamphetamine in formalin-fixed liver tissue by multistage mass spectrometry.
Shakleya DM, Kraner JC, Kaplan JA, Gannett PM, Callery PS.
Forensic Sci Int. 2006;157(2-3):87-92.


Validation of a headspace GC method for the analysis of a pyrolytic product of methamphetamine in urine.
Shakleya DM, Kraner JC, Clay DJ, Callery PS, Bell SC.
J Anal Toxicol. 2006;30(8):559-562.


Propanil exposure induces delayed but sustained abrogation of cell-mediated immunity through direct interference with cytotoxic T-lymphocyte effectors.
Sheil JM, Frankenberry MA, Schell TD, Brundage KM, Barnett JB.
Environ Health Perspect. 2006;114(7):1059-1064.

PMC1513295.

Proteasomes and their associated ATPases: a destructive combination.
Smith DM, Benaroudj N, Goldberg A.
J Struct Biol. 2006;156(1):72-83.


Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
Vredenburgh JJ, Coniglio D, Broadwater G, Jones RB, Ross M, Shpall EJ, Hussein AM, Rizzieri DA, Marks LB, Gilbert CJ, Affronti ML, Moore S, McDonald CS, Petros WP, Peters WP.
Biol Blood Marrow Transplant. 2006;12(2):195-203.


Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome.
Wenger SL, Grossfeld PD, Siu BL, Coad JE, Keller FG, Hummel M.
Am J Med Genet A. 2006;140(7):704-708.


KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions.
White DE, Negorev DG, Peng H, Ivanov AV, Maul GG, Rauscher FJ, III.
Cancer Res. 2006;66(24):11594-11599.


Phase I/II trial of intravenous doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.
Alvarez SA, Jones EL, Hahn CA, Petros WP, Yu D, Havrilesky LJ, Soper JT, Berchuck A, Spasojevic I, Clarke-Pearson DL, Prosnitz LR, Dewhirst MW.
Int J Hyperthermia. 2005;21(4):333-347.


Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors.
Arbiser JL, Li XC, Hossain CF, Nagle DG, Smith DM, Miller P, Govindarajan B, DiCarlo J, Landis-Piwowar KR, Dou QP.
J Invest Dermatol. 2005;125(2):207-212.


CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.
Bland TM, Haining RL, Tracy TS, Callery PS.
Biochem Pharmacol. 2005;70(7):1096-1103.


Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric.
Boublik J, Park H, Radisic M, Tognana E, Chen F, Pei M, Vunjak-Novakovic G, Freed LE.
Tissue Eng. 2005;11(7-8):1122-1132.


Adoptive transfer of vitiligo after allogeneic peripheral blood stem cell transplant.
Campbell-Fontaine A, Coad JE, Kovach RF, Ericson SG.
Bone Marrow Transplant. 2005;36(8):745-746.


MMP-2 is required for bone marrow stromal cell support of pro-B-cell chemotaxis.
Clutter SD, Fortney JE, Gibson LF.
Exp Hematol. 2005;33(10):1192-1200.

PMC1774816.

Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype.
Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, Bahou WF.
Thromb Haemost. 2005;94(2):412-421.


A cryoinjury model using engineered tissue equivalents for cryosurgical applications.
Han B, Grassl ED, Barocas VH, Coad JE, Bischof JC.
Ann Biomed Eng. 2005;33(7):972-982.


Dominantly inherited beta thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the beta globin gene: Hb morgantown (beta91 CTG>CG).
Luo HY, Tang W, Eung SH, Coad JE, Canfield P, Keller F, Crowell EH, Jr., Steinberg MH, Chui DH.
J Clin Pathol. 2005;58(10):1110-1112.

PMC1770750.

Identification of anhydroecgonine ethyl ester in the urine of a drug overdose victim.
Myers AL, Williams HE, Kraner JC, Callery PS.
J Forensic Sci. 2005;50(6):1481-1485.


Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience.
Paraskevas S, Coad JE, Gruessner A, Kandaswamy R, Humar A, Sutherland DE, Gruessner RW.
Transplantation. 2005;80(5):613-622.


Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer.
Petros WP, Hopkins PJ, Spruill S, Broadwater G, Vredenburgh JJ, Colvin OM, Peters WP, Jones RB, Hall J, Marks JR.
J Clin Oncol. 2005;23(25):6117-6125.


Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1.
Razorenova OV, Ivanov AV, Budanov AV, Chumakov PM.
Gene. 2005;350(1):89-98.

PMC2773277.

[Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors].
Razorenova OV, Agapova LS, Budanov AV, Ivanov AV, Strunina SM, Chumakov PM.
Mol Biol (Mosk). 2005;39(2):286-293.

PMC2774898.

Potential marker for smoked methamphetamine hydrochloride based on a gas chromatography-mass spectrometry quantification method for trans-phenylpropene.
Shakleya DM, Tarr SG, Kraner JC, Clay DJ, Callery PS.
J Anal Toxicol. 2005;29(6):552-555.


Methylation of 3,4-methylenedioxymethamphetamine in formalin-fixed human liver tissue.
Shakleya DM, Kraner JC, Kaplan JA, Callery PS.
J Anal Toxicol. 2005;29(7):715-717.


ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins.
Smith DM, Kafri G, Cheng Y, Ng D, Walz T, Goldberg AL.
Mol Cell. 2005;20(5):687-698.


Conversion of methamphetamine to N-methyl-methamphetamine in formalin solutions.
Tirumalai PS, Shakleya DM, Gannett PM, Callery PS, Bland TM, Tracy TS.
J Anal Toxicol. 2005;29(1):48-53.


MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C, Ivanov AV, Chen L, Fredericks WJ, Seto E, Rauscher FJ, III, Chen J.
EMBO J. 2005;24(18):3279-3290.

PMC1224681.

Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death.
Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham CA, Coad JE, Flynn DC, Reed E, Li QQ.
Cell Mol Life Sci. 2005;62(7-8):881-893.


VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli.
Wang L, Chen L, Benincosa J, Fortney JE, Gibson LF.
Leukemia. 2005;19(3):344-353.


VEGF-induced survival of chronic lymphocytic leukemia is independent of Bcl-2 phosphorylation.
Wang L, Coad JE, Fortney JM, Gibson LF.
Leukemia. 2005;19(8):1486-1487.


Activation of transforming growth factor-beta1/p38/Smad3 signaling in stromal cells requires reactive oxygen species-mediated MMP-2 activity during bone marrow damage.
Wang L, Clutter SD, Benincosa J, Fortney JE, Gibson LF.
Stem Cells. 2005;23(8):1122-1134.


Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.
Willis MS, McKenna RW, Peterson LC, Coad JE, Kroft SH.
Am J Clin Pathol. 2005;124(2):191-198.


Etoposide differentially affects bone marrow and dermal derived endothelial cells.
Adams SW, Wang L, Fortney JE, Gibson LF.
J Cell Mol Med. 2004;8(3):338-348.


In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia.
Bhowmick P, Coad JE, Bhowmick S, Pryor JL, Larson T, De La RJ, Bischof JC.
Int J Hyperthermia. 2004;20(4):421-439.


In vitro thermal therapy of AT-1 Dunning prostate tumours.
Bhowmick S, Coad JE, Swanlund DJ, Bischof JC.
Int J Hyperthermia. 2004;20(1):73-92.


A phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI.
Int J Radiat Oncol Biol Phys. 2004;58(3):779-785.


Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells.
Hall BM, Fortney JE, Taylor L, Wood H, Wang L, Adams SW, Davis S, Gibson LF.
Cancer Lett. 2004;207(2):229-239.


Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules.
Hall BM, Gibson LF.
Leuk Lymphoma. 2004;45(1):35-48.


Investigation of the thermal and tissue injury behaviour in microwave thermal therapy using a porcine kidney model.
He X, McGee S, Coad JE, Schmidlin F, Iaizzo PA, Swanlund DJ, Kluge S, Rudie E, Bischof JC.
Int J Hyperthermia. 2004;20(6):567-593.


Fatal hemorrhage from androgen-related hepatic adenoma after hematopoietic cell transplantation.
Kumar AR, Wagner JE, Auerbach AD, Coad JE, Dietz CA, Schwarzenberg SJ, MacMillan ML.
J Pediatr Hematol Oncol. 2004;26(1):16-18.


Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.
Lindley C, Shea T, McCune J, Shord S, Decker J, Harvey D, Petros WP, Garbriel D, Serody J, Kirby S, Wiley J.
Anticancer Drugs. 2004;15(5):453-459.


Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential.
Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ.
Blood. 2004;103(5):1662-1668.


Proteomics in platelet science.
Perrotta PL, Bahou WF.
Curr Hematol Rep. 2004;3(6):462-469.


Pharmacogenomics in cancer therapy: is host genome variability important?
Petros WP, Evans WE.
Trends Pharmacol Sci. 2004;25(9):457-464.


Proteomics in transfusion medicine.
Reddy KS, Perrotta PL.
Transfusion (Paris). 2004;44(4):601-604.


Long-term culture of tissue engineered cartilage in a perfused chamber with mechanical stimulation.
Seidel JO, Pei M, Gray ML, Langer R, Freed LE, Vunjak-Novakovic G.
Biorheology. 2004;41(3-4):445-458.


Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.
Smith DM, Daniel KG, Wang Z, Guida WC, Chan TH, Dou QP.
Proteins. 2004;54(1):58-70.


Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt.
Wang L, Fortney JE, Gibson LF.
Leuk Res. 2004;28(7):733-742.


Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion.
Cheng TY, Grubbs E, Abdul-Wahab O, Leu SY, Hung CF, Petros WP, Aloia T, Fedrau R, Pruitt S, Colvin M, Friedman HS, Tyler DS.
Am J Surg. 2003;186(5):460-467.


Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study.
Coad JE, Kosari K, Humar A, Sielaff TD.
Clin Transplant. 2003;17(4):377-384.


Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.
Dou QP, Smith DM, Daniel KG, Kazi A.
Prog Cell Cycle Res. 2003;5:441-446.


Hip pain in a case of hypophosphatemic osteomalacia.
Esterberg J, Kassim RA, Redmon J, Coad JE, Macari GS, Saleh KJ.
Am J Orthop. 2003;32(9):455-458.


Transcript profiling of human platelets using microarray and serial analysis of gene expression.
Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF.
Blood. 2003;101(6):2285-2293.


Regulation of eosinophilopoiesis in a murine model of asthma.
Hogan MB, Weissman DN, Hubbs AF, Gibson LF, Piktel D, Landreth KS.
J Immunol. 2003;171(5):2644-2651.


Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time.
Jesty J, Yin W, Perrotta PL, Bluestein D.
Platelets. 2003;14(3):143-149.


Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.
Kazi A, Daniel KG, Smith DM, Kumar NB, Dou QP.
Biochem Pharmacol. 2003;66(6):965-976.


Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability.
Kuhn DJ, Smith DM, Pross S, Whiteside TL, Dou QP.
J Cell Biochem. 2003;89(4):824-836.


Apoptotic activity in stored human platelets.
Perrotta PL, Perrotta CL, Snyder EL.
Transfusion (Paris). 2003;43(4):526-535.


Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia.
Petros WP.
Pharmacotherapy. 2003;23(8 Pt 2):1S-2S.


Cryothermic and hyperthermic treatments of human leiomyomata and adjacent myometrium and their implications for laparoscopic surgery.
Rupp CC, Nagel TC, Swanlund DJ, Bischof JC, Coad JE.
J Am Assoc Gynecol Laparosc. 2003;10(1):90-98.


Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.
Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Young SL, Schnall M, O'Dwyer PJ.
J Clin Oncol. 2003;21(23):4428-4438.


Is apoptosis an important mechanism of cryoinjury in vivo?
Bischof JC, Coad JE, Hoffmann NE, Roberts KR.
Cryo Letters. 2002;23(4):277-278.


Cholecystitis as the presenting manifestation of acute myeloid leukemia: report of a case.
Bloom SH, Coad JE, Greeno EW, Ashrani AA, Hammerschmidt DE.
Am J Hematol. 2002;70(3):254-256.


Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis.
Bohjanen PR, Johnson MD, Szczech LA, Wray DW, Petros WP, Miller CR, Hicks CB.
Antimicrob Agents Chemother. 2002;46(8):2387-2392.

PMC127386.

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.
Dowlati A, Robertson K, Cooney MM, Petros WP, Stratford M, Jesberger JA, Rafie N, Overmoyer BA, Makkar V, Stambler BS, Taylor A, Waas J, Lewin JS, McCrae KR, Remick SC.
Cancer Res. 2002;62(12):3408-3416.


Chemotherapy induces bcl-2 cleavage in lymphoid leukemic cell lines.
Fortney JE, Hall BM, Bartrug L, Gibson LF.
Leuk Lymphoma. 2002;43(11):2171-2178.


Survival of B lineage leukemic cells: signals from the bone marrow microenvironment.
Gibson LF.
Leuk Lymphoma. 2002;43(1):19-27.


Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.
Kazi A, Smith DM, Daniel KG, Zhong S, Gupta P, Bosley ME, Dou QP.
In Vivo. 2002;16(6):397-403.


Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis.
Kazi A, Smith DM, Zhong Q, Dou QP.
Mol Pharmacol. 2002;62(4):765-771.


Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Martell RE, Peterson BL, Cohen HJ, Petros WP, Rai KR, Morrison VA, Elias L, Shepherd L, Hines J, Larson RA, Schiffer CA, Hurwitz HI.
Cancer Chemother Pharmacol. 2002;50(1):37-45.


Bioreactors mediate the effectiveness of tissue engineering scaffolds.
Pei M, Solchaga LA, Seidel J, Zeng L, Vunjak-Novakovic G, Caplan AI, Freed LE.
FASEB J. 2002;16(12):1691-1694.


Growth factors for sequential cellular de- and re-differentiation in tissue engineering.
Pei M, Seidel J, Vunjak-Novakovic G, Freed LE.
Biochem Biophys Res Commun. 2002;294(1):149-154.


Applying a novel statistical process control model to platelet quality monitoring.
Perrotta PL, Ozcan C, Whitbread JA, Finch SJ.
Transfusion (Paris). 2002;42(8):1059-1066.


Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
Petros WP, Broadwater G, Berry DA, Jones RB, Vredenburgh JJ, Gilbert CJ, Gibbs JP, Colvin OM, Peters WP.
Clin Cancer Res. 2002;8(3):698-705.


Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil.
Pugacheva EN, Ivanov AV, Kravchenko JE, Kopnin BP, Levine AJ, Chumakov PM.
Oncogene. 2002;21(30):4595-4600.


Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer.
Rizvi NA, Marshall JL, Ness E, Hawkins MJ, Kessler C, Jacobs H, Brenckman WD, Jr., Lee JS, Petros WP, Hong WK, Kurie JM.
J Clin Oncol. 2002;20(16):3522-3532.


Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz HI, Moore JO.
J Clin Oncol. 2002;20(3):674-679.


Cryosurgical changes in the porcine kidney: histologic analysis with thermal history correlation.
Rupp CC, Hoffmann NE, Schmidlin FR, Swanlund DJ, Bischof JC, Coad JE.
Cryobiology. 2002;45(2):167-182.


Comparison of magnesium sulfate and sodium sulfate for removal of water from pesticide extracts of foods.
Schenck FJ, Callery PS, Gannett PM, Daft JR, Lehotay SJ.
J AOAC Int. 2002;85(5):1177-1180.


Synthetic analogs of green tea polyphenols as proteasome inhibitors.
Smith DM, Wang Z, Kazi A, Li LH, Chan TH, Dou QP.
Mol Med. 2002;8(7):382-392.

PMC2040000.

A novel beta-lactam antibiotic activates tumor cell apoptotic program by inducing DNA damage.
Smith DM, Kazi A, Smith L, Long TE, Heldreth B, Turos E, Dou QP.
Mol Pharmacol. 2002;61(6):1348-1358.


Transplacental transfer of small-cell carcinoma of the lung.
Tolar J, Coad JE, Neglia JP.
N Engl J Med. 2002;346(19):1501-1502.


Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
Barker JN, Martin PL, Coad JE, DeFor T, Trigg ME, Kurtzberg J, Weisdorf DJ, Wagner J.
Biol Blood Marrow Transplant. 2001;7(7):395-399.


Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe.
Bhowmick S, Swanlund DJ, Coad JE, Lulloff L, Hoey MF, Bischof JC.
J Endourol. 2001;15(6):629-640.


Microscopic and calorimetric assessment of freezing processes in uterine fibroid tumor tissue.
Devireddy RV, Coad JE, Bischof JC.
Cryobiology. 2001;42(4):225-243.


Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy.
Fortney JE, Zhao W, Wenger SL, Gibson LF.
Leuk Res. 2001;25(10):901-907.


Propanil inhibits tumor necrosis factor-alpha production by reducing nuclear levels of the transcription factor nuclear factor-kappab in the macrophage cell line ic-21.
Frost LL, Neeley YX, Schafer R, Gibson LF, Barnett JB.
Toxicol Appl Pharmacol. 2001;172(3):186-193.


Alteration of nuclear factor-kappaB (NF-kappaB) expression in bone marrow stromal cells treated with etoposide.
Hall BM, Fortney JE, Gibson LF.
Biochem Pharmacol. 2001;61(10):1243-1252.


Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat.
Hoffmann NE, Coad JE, Huot CS, Swanlund DJ, Bischof JC.
Cryobiology. 2001;42(1):59-68.


Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector.
Ichikawa T, Petros WP, Ludeman SM, Fangmeier J, Hochberg FH, Colvin OM, Chiocca EA.
Cancer Res. 2001;61(3):864-868.


Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo.
Nam S, Smith DM, Dou QP.
J Biol Chem. 2001;276(16):13322-13330.


Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
Nam S, Smith DM, Dou QP.
Cancer Epidemiol Biomarkers Prev. 2001;10(10):1083-1088.


Non-infectious complications of transfusion therapy.
Perrotta PL, Snyder EL.
Blood Rev. 2001;15(2):69-83.


Measurement and prediction of thermal behavior and acute assessment of injury in a pig model of renal cryosurgery.
Schmidlin FR, Rupp CC, Hoffmann NE, Coad JE, Swanlund DJ, Hulbert JC, Bischof JC.
J Endourol. 2001;15(2):193-197.


High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells.
Smirnov AS, Ruzov AS, Budanov AV, Prokhortchouk AV, Ivanov AV, Prokhortchouk EB.
Cell Death Differ. 2001;8(6):621-630.


Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis.
Smith DM, Dou QP.
Int J Mol Med. 2001;7(6):645-652.


Lymphoproliferative disorder presenting as pulmonary nodules after bone marrow transplantation.
Tolar J, Coad JE, Ramsay NK, Peters C, Davies SM.
Bone Marrow Transplant. 2001;28(8):808-810.


Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.
Bhalla KS, Wilczynski SW, Abushamaa AM, Petros WP, McDonald CS, Loftis JS, Chao NJ, Vredenburgh JJ, Folz RJ.
Am J Respir Crit Care Med. 2000;161(1):17-25.


Hematopoiesis: the role of stromal integrin interactions in Pro-B cell proliferation.
Hahn BK, Piktel D, Gibson LF, Landreth KS.
Hematology. 2000;5(2):153-160.


[Mutation of p53 is necessary for stable transformation of REF52 cells by myc+ras oncogenes].
Ivanov AV, Kopnin BP, Kondratov RV, Ossovskaya VS, Kopnin BP, Chumakov PM.
Mol Biol (Mosk). 2000;34(2):316-325.


Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW.
Cancer Res. 2000;60(24):6950-6957.


Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.
Mudry RE, Fortney JE, York T, Hall BM, Gibson LF.
Blood. 2000;96(5):1926-1932.


Treatment by methyl methanesulfonate induces up-regulation of cytomegalovirus immediate/early promoter.
Nabirochkina EN, Ivanov AV.
Biotechniques. 2000;29(4):732-4, 736.


Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies.
Ochoa L, Hurwitz HI, Wilding G, Cohen DP, Thomas JP, Schwartz G, Monroe P, Petros WP, Ertel VP, Hsieh A, Hoffman C, Drengler R, Magnum S, Rowinsky EK.
Ann Oncol. 2000;11(10):1313-1322.


Expression of collagen type I, II and III in loose body of osteoarthritis.
Pei M, Yu CL, Qu MY.
J Orthop Sci. 2000;5(3):288-293.


Integration of a hematopoietic progenitor cell program using the ACT/DB database system.
Perrotta PL, Nadkarni PM.
Comput Methods Programs Biomed. 2000;61(3):195-207.


[Identification of genes activated by mutant forms of p53].
Pugacheva EN, Ivanov AV, Snegur IE, Kopnin BP, Chumakov PM.
Mol Biol (Mosk). 2000;34(1):143-151.


P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
Agapova LS, Ivanov AV, Sablina AA, Kopnin BP, Sokova OI, Chumakov PM, Kopnin BP.
Oncogene. 1999;18(20):3135-3142.


Phase I study of doxil and vinorelbine in metastatic breast cancer.
Burstein HJ, Ramirez MJ, Petros WP, Clarke KD, Warmuth MA, Marcom PK, Matulonis UA, Parker LM, Harris LN, Winer EP.
Ann Oncol. 1999;10(9):1113-1116.


Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.
Egorin MJ, Zuhowski EG, Sentz DL, Dobson JM, Callery PS, Eiseman JL.
Cancer Chemother Pharmacol. 1999;44(4):283-294.


Irinotecan therapy in adults with recurrent or progressive malignant glioma.
Friedman HS, Petros WP, Friedman AH, Schaaf LJ, Kerby T, Lawyer J, Parry M, Houghton PJ, Lovell S, Rasheed K, Cloughsey T, Stewart ES, Colvin OM, Provenzale JM, McLendon RE, Bigner DD, Cokgor I, Haglund M, Rich J, Ashley D, Malczyn J, Elfring GL, Miller LL.
J Clin Oncol. 1999;17(5):1516-1525.


Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF, Fortney JE, Magro G, Ericson SG, Lynch JP, Landreth KS.
Breast Cancer Res Treat. 1999;55(2):107-117.


Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.
Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmelinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, de Lorenzo D, Fu YX, Musser JM.
Nat Med. 1999;5(8):924-929.


Effects of methylene blue-treated plasma on red cells and stored platelet concentrates.
Perrotta PL, Baril L, Tead C, Chapman J, Dincecco D, Buchholz DH, Snyder EL.
Transfusion (Paris). 1999;39(1):63-69.


Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease.
Perry JJ, Fleming RA, Rocco MV, Petros WP, Bleyer AJ, Radford JE, Jr., Powell BL, Hurd DD.
Bone Marrow Transplant. 1999;23(8):839-842.


Metabolic jeopardy with high-dose cyclophosphamide?--not so fast.
Petros WP, Colvin OM.
Clin Cancer Res. 1999;5(4):723-724.


Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
Rizzieri DA, Vredenburgh JJ, Jones RB, Ross M, Shpall EJ, Hussein AM, Broadwater G, Berry DA, Petros WP, Gilbert CJ, Affronti ML, Coniglio D, Rubin P, Elkordy M, Long GD, Chao NJ, Peters WP.
J Clin Oncol. 1999;17(10):3064-3074.


Inducible nitric oxide synthase with transitional cell carcinoma of the bladder.
Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM.
J Urol. 1999;161(2):630-634.


Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring.
Taylor CT, Petros WP, Ortel TL.
Pharmacotherapy. 1999;19(4):383-387.


Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Egorin MJ, Rosen DM, Wolff JH, Callery PS, Musser SM, Eiseman JL.
Cancer Res. 1998;58(11):2385-2396.


Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
Eiseman JL, Rogers FA, Guo Y, Kauffman J, Sentz DL, Klinger MF, Callery PS, Kyprianou N.
Cancer Res. 1998;58(21):4864-4870.


Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor.
Ericson SG, Zhao Y, Gao H, Miller KL, Gibson LF, Lynch JP, Landreth KS.
Blood. 1998;91(6):2099-2107.


Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver.
Fisher DC, Vredenburgh JJ, Petros WP, Hussein AM, Berry DA, Elkordy M, Rubin P, Gilbert CJ, Peters WP.
Bone Marrow Transplant. 1998;21(2):117-122.


Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer.
Gilbert CJ, Petros WP, Vredenburgh JJ, Hussein AM, Ross M, Rubin P, Fehdrau R, Cavanaugh C, Berry DA, McKinstry C, Peters WP.
Cancer Chemother Pharmacol. 1998;42(6):497-503.


Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.
Maher MG, Sapi E, Turner B, Gumbs A, Perrotta PL, Carter D, Kacinski BM, Haffty BG.
Clin Cancer Res. 1998;4(8):1851-1856.


Aminoalkylaziridines as substrates and inhibitors of lysyl oxidase: specific inactivation of the enzyme by N-(5-aminopentyl)aziridine.
Nagan N, Callery PS, Kagan HM.
Front Biosci. 1998;3:A23-A26.


Liesegang rings and endometriosis.
Perrotta PL, Ginsburg FW, Siderides CI, Parkash V.
Int J Gynecol Pathol. 1998;17(4):358-362.


Effect of plasma TNF-alpha on filgrastim-stimulated hematopoiesis in mice and humans.
Petros WP, Rabinowitz J, Gibbs JP, Hall IH, Stuart AR, Peters WP.
Pharmacotherapy. 1998;18(4):816-823.


Chromatographic methods of analysis of antibiotics in milk.
Schenck FJ, Callery PS.
J Chromatogr A. 1998;812(1-2):99-109.


New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
Smith PF, Petros WP, Soucie MP, Copeland KR.
Ther Drug Monit. 1998;20(2):231-235.


The addition of paclitaxel to continuous infusion 5-fluorouracil is an active regimen for metastatic breast cancer.
Vredenburgh JJ, Fishman R, Coniglio D, Matters L, Elkordy M, Ross M, Hussein AM, Rubin P, Gilbert CJ, Petros WP, Peters WP.
Am J Clin Oncol. 1998;21(6):543-547.


Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer.
Wilczynski SW, Erasmus JJ, Petros WP, Vredenburgh JJ, Folz RJ.
Am J Respir Crit Care Med. 1998;157(2):565-573.


Perinodular hydropic degeneration of a uterine leiomyoma: a diagnostic challenge.
Coad JE, Sulaiman RA, Das K, Staley N.
Hum Pathol. 1997;28(2):249-251.


Microcephaly with agenesis of corticospinal tracts and arthrogryposis, hypospadias, single umbilical artery, hypertelorism, and renal and adrenal hypoplasia--previously undescribed syndrome.
Coad JE, Angel C, Pierpont ME, Gorlin RJ, Anderson ML.
Am J Med Genet A. 1997;71(4):458-462.


Molecular assessment of clonality in lymphoproliferative disorders: II. T-cell receptor gene rearrangements.
Coad JE, Olson DJ, Lander TA, McGlennen RC.
Mol Diagn. 1997;2(1):69-81.


Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas.
Coad JE, Olson DJ, Christensen DR, Lander TA, Chibbar R, McGlennen RC, Brunning RD.
Am J Surg Pathol. 1997;21(9):1047-1056.


In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene.
Egorin MJ, Rosen DM, Benjamin SE, Callery PS, Sentz DL, Eiseman JL.
Cancer Chemother Pharmacol. 1997;41(1):9-14.


A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein AM, Rubin P, Ross M, Gilbert CJ, Modlin C, Meisenberg B, Coniglio D, Rabinowitz J, Laughlin MJ, Kurtzberg J, Peters WP.
Bone Marrow Transplant. 1997;19(4):315-322.


Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.
Flick MB, Sapi E, Perrotta PL, Maher MG, Halaban R, Carter D, Kacinski BM.
Oncogene. 1997;14(21):2553-2561.


A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy.
Gattis WA, Petros WP, Pickard WW, Drew RH, May DB, Hathorn JW.
Pharmacotherapy. 1997;17(4):836-840.


Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters.
Geiger TL, Perrotta PL, Davenport R, Baril L, Snyder EL.
Transfusion (Paris). 1997;37(11-12):1156-1162.


Disruption of bone marrow stromal cell function by etoposide.
Gibson LF, Fortney JE, Landreth KS, Piktel D, Ericson SG, Lynch JP.
Biol Blood Marrow Transplant. 1997;3(3):122-132.


Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft.
Hare CB, Elion GB, Colvin OM, Ali-Osman F, Griffith OW, Petros WP, Keir S, Marcelli SL, Bigner DD, Friedman HS.
Cancer Chemother Pharmacol. 1997;40(5):409-414.


Comparative molecular field analysis-based predictive model of structure-function relationships of polyamine transport inhibitors in L1210 cells.
Li Y, MacKerell AD, Jr., Egorin MJ, Ballesteros MF, Rosen DM, Wu YY, Blamble DA, Callery PS.
Cancer Res. 1997;57(2):234-239.


Clinical pharmacology of filgrastim following high-dose chemotherapy and autologous bone marrow transplantation.
Petros WP, Rabinowitz J, Stuart AR, Peters WP.
Clin Cancer Res. 1997;3(5):705-711.


Safety of concomitant use of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor with cytotoxic chemotherapy agents.
Petros WP, Crawford J.
Curr Opin Hematol. 1997;4(3):213-216.


Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations.
Piscitelli SC, Reiss WG, Figg WD, Petros WP.
Clin Pharmacokinet. 1997;32(5):368-381.


Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
Sutton LM, Warmuth MA, Petros WP, Winer EP.
Cancer Chemother Pharmacol. 1997;40(4):335-341.


The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support.
Vredenburgh JJ, Silva O, Broadwater G, Berry DA, DeSombre K, Tyer C, Petros WP, Peters WP, Bast RC, Jr.
Biol Blood Marrow Transplant. 1997;3(2):91-97.


[Induction of hyperdiploidy and chromosome breaks in LIM1215 cells expressing the exogenous mutant p53].
Agapova LS, Turovets NA, Ivanov AV, Il'inskaia GV, Chumakov PM.
Genetika. 1996;32(8):1080-1087.


Molecular assessment of clonality in lymphoproliferative disorders: I. Immunoglobulin gene rearrangements.
Coad JE, Olson DJ, Lander TA, McGlennen RC.
Mol Diagn. 1996;1(4):335-355.


Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii.
Egorin MJ, Sentz DL, Rosen DM, Ballesteros MF, Kearns CM, Callery PS, Eiseman JL.
Cancer Chemother Pharmacol. 1996;39(1-2):51-60.


Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice.
Eiseman JL, Yuan ZM, Eddington ND, Sentz DL, Callery PS, Egorin MJ.
Cancer Chemother Pharmacol. 1996;38(1):13-20.


Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.
Fisher DC, Sherrill GB, Hussein AM, Rubin P, Vredenburgh JJ, Elkordy M, Ross M, Petros WP, Peters WP.
Bone Marrow Transplant. 1996;18(1):193-198.


Stromal cells regulate bcl-2 and bax expression in pro-B cells.
Gibson LF, Piktel D, Narayanan R, Nunez G, Landreth KS.
Exp Hematol. 1996;24(5):628-637.


A phase I/II study of high-dose cyclophosphamide, cisplatin, and thiotepa followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies.
Hussein AM, Petros WP, Ross M, Vredenburgh JJ, Affronti ML, Jones RB, Shpall EJ, Rubin P, Elkordy M, Gilbert CJ, Gupton C, Egorin MJ, Soper JT, Berchuck A, Clarke-Pearson DL, Berry DA, Peters WP.
Cancer Chemother Pharmacol. 1996;37(6):561-568.


Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer.
Khawly JA, Rubin P, Petros WP, Peters WP, Jaffe GJ.
Ophthalmology. 1996;103(1):87-95.


Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane.
Li Y, Eiseman JL, Sentz DL, Rogers FA, Pan SS, Hu LT, Egorin MJ, Callery PS.
J Med Chem. 1996;39(1):339-341.


The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline.
Petros WP, Rosner GL, Rabinowitz J, Gilbert CJ, Coniglio D, Vredenburgh JJ, Ross M, Peters WP.
Pharmacotherapy. 1996;16(5):742-748.


Carboplatin pharmacokinetics in young children with brain tumors.
Tonda ME, Heideman RL, Petros WP, Friedman HS, Murry DJ, Rodman JH.
Cancer Chemother Pharmacol. 1996;38(5):395-400.


Artifactual hypoglycemia associated with hematopoietic cytokines.
Astles JR, Petros WP, Peters WP, Sedor FA.
Arch Pathol Lab Med. 1995;119(8):713-716.


Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study.
Cartee L, Petros WP, Rosner GL, Gilbert CJ, Moore S, Affronti ML, Hoke JA, Hussein AM, Ross M, Rubin P.
Cytokine. 1995;7(5):471-477.


Effects of the submarine environment on renal-stone risk factors and vitamin D metabolism.
Dlugos DJ, Perrotta PL, Horn WG.
Undersea Hyperb Med. 1995;22(2):145-152.


Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Hussein AM, Ross M, Vredenburgh JJ, Meisenberg B, Hars V, Gilbert CJ, Petros WP, Coniglio D, Kurtzberg J, Rubin P.
Eur J Haematol. 1995;55(5):348-356.


The efficacy of the placental biopsy.
Kliman HJ, Perrotta PL, Jones DC.
Am J Obstet Gynecol. 1995;173(4):1084-1088.


Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
Kurpad SN, Friedman HS, Archer GE, McLendon RE, Petros WP, Fuchs HE, Guaspari A, Bigner DD.
Cancer Res. 1995;55(17):3803-3809.


Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity.
Murase T, Anscher MS, Petros WP, Peters WP, Jirtle RL.
Bone Marrow Transplant. 1995;15(2):173-178.


Superantigens and their role in infectious disease.
Schafer R, Sheil JM.
Adv Pediatr Infect Dis. 1995;10:369-390.


Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule.
Sun R, Shepherd SE, Geier SS, Thomson CT, Sheil JM, Nathenson SG.
Immunity. 1995;3(5):573-582.


Late-developing Philadelphia chromosomes in a case of T-cell acute lymphoblastic leukemia.
Coad JE, Arthur DC, Gajl-Peczalska KJ, Litz CE.
Leukemia. 1994;8(5):889-894.


Elevated endogenous serum macrophage colony-stimulating factor in the early stage of fungemia following bone marrow transplantation.
Petros WP, Rabinowitz J, Stuart AR, Gupton C, Alderman EM, Peters WP.
Exp Hematol. 1994;22(7):582-586.


Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trial.
Petros WP, Chaney SG, Smith DC, Fangmeier J, Sakata M, Brown TD, Trump DL.
Cancer Chemother Pharmacol. 1994;33(4):347-354.


Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM, Schell TD, Shepherd SE, Klimo GF, Kioschos JM, Paterson Y.
Eur J Immunol. 1994;24(9):2141-2149.


Treatment of carbon monoxide poisoning: a critical review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen.
Tibbles PM, Perrotta PL.
Ann Emerg Med. 1994;24(2):269-276.


Cytotoxic activity of N1- and N8-aziridinyl analogs of spermidine.
Yuan ZM, Rosen DM, Egorin MJ, Callery PS.
Biochem Pharmacol. 1994;47(9):1587-1592.


Cellular pharmacology of N1- and N8-aziridinyl analogues of spermidine.
Yuan ZM, Egorin MJ, Rosen DM, Simon MA, Callery PS.
Cancer Res. 1994;54(3):742-748.


Minor pocket B influences peptide binding, peptide presentation and alloantigenicity of H-2Kb.
Yun TJ, Tallquist MD, Rohren EM, Sheil JM, Pease LR.
Int Immunol. 1994;6(7):1037-1047.


Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.
Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL.
N Engl J Med. 1993;328(22):1592-1598.


Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature.
Coad JE, Matutes E, Catovsky D.
Leuk Lymphoma. 1993;10(4-5):245-264.


Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells.
Gibson LF, Piktel D, Landreth KS.
Blood. 1993;82(10):3005-3011.


Alkylamides as inducers of human leukemia cell differentiation: a quantitative structure-activity relationship study using comparative molecular field analysis.
Harpalani AD, Snyder SW, Subramanyam B, Egorin MJ, Callery PS.
Cancer Res. 1993;53(4):766-771.


High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathways.
Karolak L, Chandra A, Khan W, Marks B, Petros WP, Peters WP, Greenberg CS, Hannun YA.
Mol Pharmacol. 1993;43(1):37-44.


Role of cytokines in autologous bone marrow transplantation.
Peters WP, Ross M, Vredenburgh JJ, Hussein AM, Meisenberg B, Gilbert CJ, Petros WP, Kurtzberg J.
Hematol Oncol Clin North Am. 1993;7(3):737-747.


High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.
Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer EP, Kurtzberg J, Bast RC, Jr., Jones RB, Shpall EJ, Wu K, Rosner GL, Gilbert CJ, Mathias B, Coniglio D, Petros WP, Henderson C, Norton L, Weiss R, Hurd DD.
J Clin Oncol. 1993;11(6):1132-1143.


Cost implications of haematopoietic growth factors in the BMT setting.
Petros WP, Peters WP.
Bone Marrow Transplant. 1993;11 Suppl 2:36-38.


Hematopoietic colony-stimulating factors and dose intensity.
Petros WP, Peters WP.
Semin Oncol. 1993;20(1):94-99.


Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
Rabinowitz J, Petros WP, Stuart AR, Peters WP.
Blood. 1993;81(9):2452-2459.


Peptide competition studies suggest the possible binding of 2 Ctl-recognized peptides to a single class-I Mhc molecule.
Schell T, Paterson Y, Sheil JM.
J Immunol. 1993;150(8):A39-A39.


Isotopically sensitive regioselectivity in the oxidative deamination of a homologous series of diamines catalyzed by diamine oxidase.
Callery PS, Subramanyam B, Yuan ZM, Pou S, Geelhaar LA, Reynolds KA.
Chem Biol Interact. 1992;85(1):15-26.


Inhibition of restriction endonucleases by common clinical anticoagulants.
Coad JE, Lander TA, Litz CE.
Anal Biochem. 1992;205(2):368-369.


Active-site directed irreversible inhibition of diamine oxidase by a homologous series of aziridinylalkylamines.
Conner JW, Yuan ZM, Callery PS.
Biochem Pharmacol. 1992;44(6):1229-1232.


Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
Evans WE, Rodman JH, Relling MV, Petros WP, Stewart CF, Pui CH, Rivera GK.
J Pharmacol Exp Ther. 1992;260(1):71-77.


Methylation status of the major breakpoint cluster region in Philadelphia chromosome negative leukemias.
Litz CE, McClure JS, Coad JE, Goldfarb AN, Brunning RD.
Leukemia. 1992;6(1):35-41.


Alkylation of DNA with aziridine produced during the hydrolysis of N,N',N''-triethylenethiophosphoramide.
Musser SM, Pan SS, Egorin MJ, Kyle DJ, Callery PS.
Chem Res Toxicol. 1992;5(1):95-99.


Pharmacokinetics and administration of colony-stimulating factors.
Petros WP.
Pharmacotherapy. 1992;12(2 Pt 2):32S-38S.


Disposition of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving high-dose chemotherapy and autologous bone marrow support.
Petros WP, Rabinowitz J, Stuart AR, Gilbert CJ, Kanakura Y, Griffin JD, Peters WP.
Blood. 1992;80(5):1135-1140.


Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.
Petros WP, Rodman JH, Relling MV, Christensen M, Pui CH, Rivera GK, Evans WE.
Pharmacotherapy. 1992;12(4):273-277.


Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.
Sheil JM, Shepherd SE, Klimo GF, Paterson Y.
J Exp Med. 1992;175(2):545-552.

PMC2119120.

Selective reactivity of CD8-independent T lymphocytes to a cytotoxic T lymphocyte-selected H-2Kb mutant altered at position 222 in the alpha 3 domain.
Shepherd SE, Sun R, Nathenson SG, Sheil JM.
Eur J Immunol. 1992;22(3):647-653.


Familial hemifacial spasm associated with arterial compression of the facial nerve. Case report.
Coad JE, Wirtschafter JD, Haines SJ, Heros RC, Perrone T.
J Neurosurg. 1991;74(2):290-296.


Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
Furman WL, Fairclough DL, Huhn RD, Pratt CB, Stute N, Petros WP, Evans WE, Bowman LC, Douglass EC, Santana VM.
J Clin Oncol. 1991;9(6):1022-1028.


Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study.
Litz CE, Arthur DC, Gajl-Peczalska KJ, Rausch D, Copenhaver C, Coad JE, Brunning RD.
Leukemia. 1991;5(11):972-978.


Pharmacokinetics of continuous-infusion amsacrine and teniposide for the treatment of relapsed childhood acute nonlymphocytic leukemia.
Petros WP, Rodman JH, Mirro J, Jr., Evans WE.
Cancer Chemother Pharmacol. 1991;27(5):397-400.


Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects.
Relling MV, Cherrie J, Schell MJ, Petros WP, Meyer WH, Evans WE.
Clin Pharmacol Ther. 1991;50(3):308-313.


Induction of human leukemia cell differentiation by regiospecifically acetylated spermidines.
Snyder SW, Egorin MJ, Callery PS.
Biochem Biophys Res Commun. 1991;180(2):591-596.


Supercritical fluid chromatography/chemical ionization/mass spectrometry of some anticancer drugs in a thermospray ion source.
Musser SM, Callery PS.
Biomed Environ Mass Spectrom. 1990;19(6):348-352.


Pharmacokinetics and pharmacodynamics of anticancer agents: contributions to the therapy of childhood cancer.
Petros WP, Evans WE.
Pharmacotherapy. 1990;10(5):313-325.


Effects of the monoamine oxidase inhibitor, tranylcypromine, on induction of HL60 cell differentiation by hexamethylene bisacetamide and N-acetyl-1,6-diaminohexane.
Snyder SW, Egorin MJ, Zuhowski EG, Schimpff EC, Callery PS.
Cancer Commun. 1990;2(7):231-236.


Clinical pharmacology of cancer chemotherapy in children.
Evans WE, Petros WP, Relling MV, Crom WR, Madden T, Rodman JH, Sunderland M.
Pediatr Clin North Am. 1989;36(5):1199-1230.


Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.
Evans WE, Relling MV, Petros WP, Meyer WH, Mirro J, Jr., Crom WR.
Clin Pharmacol Ther. 1989;45(5):568-573.


Derivatization of N-methyl and cyclic amino acids with dimethylformamide dimethyl acetal.
Grubb MF, Callery PS.
J Chromatogr. 1989;469:191-196.


Analysis of neuroelectric implant integrity.
Harris GF, Hemmy DC, Coad JE, Mothkur SR, Weber RC.
Stereotact Funct Neurosurg. 1989;52(1):63-71.


Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
Musser SM, Pan SS, Callery PS.
J Chromatogr. 1989;474(1):197-207.


Use of mutants to analyze regions on the H-2Kb molecule for interaction with immune receptors.
Nathenson SG, Kesari K, Sheil JM, Ajitkumar P.
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:521-528.


A nuclear magnetic resonance (NMR) method for the determination of the cis/trans isomeric content of chlorprothixene.
Rosler KH, Wright J, Fox KM, Waters RM, Callery PS.
Pharm Res. 1989;6(8):706-708.


An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.
Subramanyam B, Callery PS, Egorin MJ, Snyder SW, Conley BA.
Drub Metab Dispos. 1989;17(4):398-401.


A cyclic imine intermediate in the in vitro metabolic conversion of 1,6-diaminohexane to 6-aminohexanoic acid and caprolactam.
Subramanyam B, Callery PS, Geelhaar LA, Egorin MJ.
Xenobiotica. 1989;19(1):33-42.


Metabolic conversion of 2-propylpentanal acetals to valproic acid in vitro. Model prodrugs of carboxylic acid agents.
Vicchio D, Callery PS.
Drub Metab Dispos. 1989;17(5):513-517.


Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
Carbone FR, Moore MW, Sheil JM, Bevan MJ.
J Exp Med. 1988;167(6):1767-1779.

PMC2189675.

Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA).
Conley BA, Callery PS, Egorin MJ, Subramanyam B, Geelhaar LA, Pan SS.
Life Sci. 1988;43(9):793-800.


Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.
Egorin MJ, Snyder SW, Cohen AS, Zuhowski EG, Subramanyam B, Callery PS.
Cancer Res. 1988;48(7):1712-1716.


Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW, Egorin MJ, Geelhaar LA, Hamburger AW, Callery PS.
Cancer Res. 1988;48(13):3613-3616.


Silylated N,O-ketals from the reaction of ketones with N-trimethylsilylimidazole.
Andrews PA, Bachur NR, Musser SM, Wright J, Callery PS.
J Chromatogr. 1987;419:271-274.


Class I-restricted cytotoxic T-cell responses to a soluble-protein antigen.
Bevan MJ, Carbone FR, Sheil JM, Wegmann DR.
J Cell Biochem. 1987;202-202.


Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites.
Egorin MJ, Zuhowski EG, Cohen AS, Geelhaar LA, Callery PS, Van Echo DA.
Cancer Res. 1987;47(22):6142-6146.


Gas chromatographic analysis of metabolites of the cell differentiating agent hexamethylene bisacetamide.
Egorin MJ, Zuhowski EG, Nayar MS, Callery PS.
J Chromatogr. 1987;415(1):148-155.


The chemical reduction of diaziquone: products and free radical intermediates.
Gutierrez PL, Balachandran Nayar MS, Nardino R, Callery PS.
Chem Biol Interact. 1987;64(1-2):23-37.


Thoracic suspension: quantitative effects upon seating pressure and posture.
Harris GF, Coad JE, Pudlowski R, Abraham EA, Millar EA.
Paraplegia. 1987;25(6):446-453.


Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM, Bevan MJ, Lefrancois L.
J Immunol. 1987;138(11):3654-3660.


Generation of Ovalbumin-specific, class I-restricted cytotoxic lymphocytes-T.
Sheil JM, Carbone FR, Wegmann DR, Bevan MJ.
Fed Proc. 1987;46(4):1343-1343.


Gas chromatographic-mass spectrometric determination of tryptophan transaminase-catalyzed deuterium exchange.
Vicchio D, Speedie MK, Callery PS.
J Chromatogr. 1987;415(1):104-109.


Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.
Callery PS, Egorin MJ, Geelhaar LA, Nayar MS.
Cancer Res. 1986;46(10):4900-4903.


A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implications.
Petros WP, Shank WA, Jr.
Hosp Pharm. 1986;21(7):648-6.


Immunoselection of structural H-2Kb variants: use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant.
Sheil JM, Bevan MJ, Sherman LA.
Immunogenetics. 1986;23(1):52-59.


1-Piperideine as an in vivo precursor of the gamma-aminobutyric acid homologue 5-aminopentanoic acid.
Callery PS, Geelhaar LA.
J Neurochem. 1985;45(3):946-948.


Superoxide radical reactions with anthracycline antibiotics.
Nakazawa H, Andrews PA, Callery PS, Bachur NR.
Biochem Pharmacol. 1985;34(4):481-490.


Putrescine metabolism: enzymatic formation and non-enzymatic isotope exchange of delta1-pyrroline.
Callery PS, Nayar MS, Geelhaar LA.
Biomed Mass Spectrom. 1984;11(3):118-120.


Biosynthesis of 5-aminopentanoic acid and 2-piperidone from cadaverine and 1-piperideine in mouse.
Callery PS, Geelhaar LA.
J Neurochem. 1984;43(6):1631-1634.


Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
Sheil JM, Gallimore PH, Zimmer SG, Sopori ML.
J Immunol. 1984;132(3):1578-1582.


Qualitative analysis of trimethylsilylated daunosamine and N-alkylated analogs by gas chromatography--mass spectrometry.
Andrews PA, Callery PS, Chou FT, May ME, Bachur NR.
Anal Biochem. 1982;126(2):258-267.


Intermolecular and intramolecular isotope effects in the deamination of putrescine catalyzed by diamine oxidase.
Callery PS, Nayar MS, Jakubowski EM, Stogniew M.
Experientia. 1982;38(4):431-433.


Pyrrolines as prodrugs of gamma-aminobutyric acid analogues.
Callery PS, Geelhaar LA, Nayar MS, Stogniew M, Rao KG.
J Neurochem. 1982;38(4):1063-1067.


Heterogeneity among cyto-toxic target determinants on adenovirus-2 (Ad 2)-transformed cell-lines.
Sheil JM, Sopori ML, Zimmer SG.
Fed Proc. 1981;40(3):1149-1149.


T-lymphocyte heterogeneity in rat: role of adherent T-cell subpopulation in the regulation of cytotoxic T-cell response to alloantigens.
Sopori ML, Sheil JM, Roszman TL, Brooks WH.
Cell Immunol. 1981;65(1):103-114.


Applications of deuterium labeling in the study of the in vitro conversion of delta 1-pyrroline to 4-aminobutanoic acid and 2-pyrrolidinone.
Callery PS, Nayar MS, Geelhaar LA, Stogniew M, Jakubowski EM.
Biomed Mass Spectrom. 1980;7(11-12):525-528.


Detection of the in vivo conversion of 2-pyrrolidinone to gamma-aminobutyric acid in mouse brain.
Callery PS, Stogniew M, Geelhaar LA.
Biomed Mass Spectrom. 1979;6(1):23-26.


Synthesis and preliminary biological studies of 4- and 5-[2-hydroxy-3-(isopropylamino)propoxy]benzimidazoles: selective beta2 adrenergic blocking agents.
Crooks CR, Wright J, Callery PS, Moreton JE.
J Med Chem. 1979;22(2):210-214.


Membrane transport of Tc-99m-labeled radiopharmaceuticals, I. Brain uptake by passive transport.
Loberg MD, Corder EH, Fields AT, Callery PS.
J Nucl Med. 1979;20(11):1181-1188.


Evidence for reduction of the leukocyte chemotactic response to endotoxin by human platelets.
Sheil JM, Walker RI.
Toxicon. 1979;17(2):173-176.


2-pyrrolidinone--a cyclization product of gamma-aminobutyric acid detected in mouse brain.
Callery PS, Geelhaar LA, Stogniew M.
Biochem Pharmacol. 1978;27(16):2061-2063.


Biologic properties of bacterial lipopolysaccharides treated with chromium chloride.
Snyder SL, Walker RI, MacVittie TJ, Sheil JM.
Can J Microbiol. 1978;24(5):495-501.


N-Methylation of benzimidazole by catechol-O-methyltransferase.
Arnett CD, Callery PS, Zenker N.
Biochem Pharmacol. 1977;26(5):377-380.


Thermal decomposition of 1,3-dimethyl derivative of phenobarbital in trimethylanilinium hydroxide.
Callery PS, Leslie J.
J Pharm Sci. 1977;66(4):578-580.


In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction.
McGraw NP, Callery PS, Castagnoli N, Jr.
J Med Chem. 1977;20(2):185-189.


Letter: Decomposition of 1,3-dimethylphenobarbital in trimethylanilinium hydroxide.
Callery PS, Leslie J.
Clin Chem. 1976;22(6):926-927.


Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid.
Callery PS, Faith WC, Loberg MD, Fields AT, Harvey EB, Cooper MD.
J Med Chem. 1976;19(7):962-964.


A convenient synthesis of quinones from hydroquinone dimethyl ethers. Oxidative demethylation with ceric ammonijm nitrate.
Jacob P, III, Callery PS, Shulgin AT, Castagnoli N, Jr.
J Org Chem. 1976;41(22):3627-3629.


Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid.
Loberg MD, Cooper M, Harvey E, Callery PS, Faith W.
J Nucl Med. 1976;17(7):633-638.


Peritoneal macrophage chemotactic response and accumulation in mice injected with Lewis Lung (3Ll) carcinoma cells.
Sheil JM, Crawford RM, Ledney CD.
Exp Hematol. 1976;4:127-127.


Contribution of granulocytopenia to endotoxin sensitivity of mice irradiated or undergoing graft-versus-host reaction.
Walker RI, Sheil JM.
Exp Hematol. 1976;4(6):329-338.


Application of chemical ionization mass spectrometry to the study of stereoselective in vitro metabolism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Weinkam RJ, Gal J, Callery PS, Castagnoli N, Jr.
Anal Chem. 1976;48(1):203-209.


Stereochemical aspects and metabolite formation in the in vivo metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Matin SB, Callery PS, Zweig JS, O'Brien A, Rapoport R, Castagnoli N, Jr.
J Med Chem. 1974;17(8):877-882.